{ "version": "2.2", "instance": { "vsee-20241231x10k.htm": { "nsprefix": "vsee", "nsuri": "http://vseehealth.com/20241231", "dts": { "schema": { "local": [ "vsee-20241231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "vsee-20241231_cal.xml" ] }, "definitionLink": { "local": [ "vsee-20241231_def.xml" ] }, "labelLink": { "local": [ "vsee-20241231_lab.xml" ] }, "presentationLink": { "local": [ "vsee-20241231_pre.xml" ] }, "inline": { "local": [ "vsee-20241231x10k.htm" ] } }, "keyStandard": 425, "keyCustom": 261, "axisStandard": 42, "axisCustom": 1, "memberStandard": 56, "memberCustom": 130, "hidden": { "total": 51, "http://fasb.org/us-gaap/2024": 33, "http://vseehealth.com/20241231": 13, "http://xbrl.sec.gov/dei/2024": 5 }, "contextCount": 762, "entityCount": 1, "segmentCount": 217, "elementCount": 1169, "unitCount": 12, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 1968, "http://xbrl.sec.gov/dei/2024": 46, "http://xbrl.sec.gov/cyd/2024": 9, "http://xbrl.sec.gov/ecd/2024": 5 }, "report": { "R1": { "role": "http://vseehealth.com/role/DocumentDocumentAndEntityInformation", "longName": "995200090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "longName": "995200100 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R3": { "role": "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals", "longName": "995200105 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R4": { "role": "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations", "longName": "995200200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R5": { "role": "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "longName": "995200300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "As_Of_12_31_2022_srt_RestatementAxis_srt_ScenarioPreviouslyReportedMember_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember_us-gaap_StatementEquityComponentsAxis_us-gaap_PreferredStockMember_uOgrifQgCE676NXuQg2p4w", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember_U936YnRjokibqslhD8BRGg", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R6": { "role": "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals", "longName": "995200305 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parentheticals)", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_BusinessAcquisitionAxis_vsee_ThisAmericanDocIncMember_BiKGDw8BfUuhLEocg-epyw", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R7": { "role": "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "995200400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_6_30_2024_2zuSxba-mkyhb4yINLAE0Q", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:ReceivablesCreditLossExpenseReversal", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R8": { "role": "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "longName": "995200405 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_BusinessAcquisitionAxis_vsee_ThisAmericanDocIncMember_BiKGDw8BfUuhLEocg-epyw", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R9": { "role": "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusiness", "longName": "995210101 - Disclosure - Organization and Description of Business", "shortName": "Organization and Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatements", "longName": "995210201 - Disclosure - Restatement of Previously Issued Financial Statements", "shortName": "Restatement of Previously Issued Financial Statements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ErrorCorrectionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ErrorCorrectionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "longName": "995210301 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://vseehealth.com/role/DisclosureBusinessCombination", "longName": "995210401 - Disclosure - Business Combination", "shortName": "Business Combination", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://vseehealth.com/role/DisclosureFixedAssets", "longName": "995210501 - Disclosure - Fixed Assets", "shortName": "Fixed Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://vseehealth.com/role/DisclosureLeases", "longName": "995210601 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilities", "longName": "995210701 - Disclosure - Accounts Payable and Accrued Liabilities", "shortName": "Accounts Payable and Accrued Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://vseehealth.com/role/DisclosureFactoringPayable", "longName": "995210801 - Disclosure - Factoring Payable", "shortName": "Factoring Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:FactoringPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:FactoringPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscount", "longName": "995210901 - Disclosure - Line of Credit and Notes Payable, Net of Discount", "shortName": "Line of Credit and Notes Payable, Net of Discount", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://vseehealth.com/role/DisclosureRelatedParty", "longName": "995211001 - Disclosure - Related Party", "shortName": "Related Party", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRisk", "longName": "995211101 - Disclosure - Commitments, Contingencies, and Concentration Risk", "shortName": "Commitments, Contingencies, and Concentration Risk", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://vseehealth.com/role/DisclosureIncomeTaxes", "longName": "995211201 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://vseehealth.com/role/DisclosureEquity", "longName": "995211301 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://vseehealth.com/role/DisclosureWarrants", "longName": "995211401 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://vseehealth.com/role/DisclosureReportableSegments", "longName": "995211501 - Disclosure - Reportable Segments", "shortName": "Reportable Segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurements", "longName": "995211601 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://vseehealth.com/role/DisclosureSubsequentEvents", "longName": "995211701 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "Duration_10_1_2024_To_12_31_2024_On4YtFRsDEGFKVGOqk5Ylg", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2024_To_12_31_2024_On4YtFRsDEGFKVGOqk5Ylg", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc", "longName": "995447 - Disclosure - Insider Trading Policies and Procedures", "shortName": "Insider Trading Policies and Procedures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R29": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R30": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "99920302 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "30", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R31": { "role": "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsTables", "longName": "99930203 - Disclosure - Restatement of Previously Issued Financial Statements (Tables)", "shortName": "Restatement of Previously Issued Financial Statements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "99930303 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R33": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationTables", "longName": "99930403 - Disclosure - Business Combination (Tables)", "shortName": "Business Combination (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://vseehealth.com/role/DisclosureFixedAssetsTables", "longName": "99930503 - Disclosure - Fixed Assets (Tables)", "shortName": "Fixed Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://vseehealth.com/role/DisclosureLeasesTables", "longName": "99930603 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R36": { "role": "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesTables", "longName": "99930703 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R37": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountTables", "longName": "99930903 - Disclosure - Line of Credit and Notes Payable, Net of Discount (Tables)", "shortName": "Line of Credit and Notes Payable, Net of Discount (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R38": { "role": "http://vseehealth.com/role/DisclosureIncomeTaxesTables", "longName": "99931203 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R39": { "role": "http://vseehealth.com/role/DisclosureEquityTables", "longName": "99931303 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R40": { "role": "http://vseehealth.com/role/DisclosureWarrantsTables", "longName": "99931403 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R41": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsTables", "longName": "99931503 - Disclosure - Reportable Segments (Tables)", "shortName": "Reportable Segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R42": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "longName": "99931603 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "longName": "99940101 - Disclosure - Organization and Description of Business (Details)", "shortName": "Organization and Description of Business (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:SubstantialDoubtAboutGoingConcernWithinOneYear", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R44": { "role": "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "longName": "99940201 - Disclosure - Restatement of Previously Issued Financial Statements - Narratives (Details)", "shortName": "Restatement of Previously Issued Financial Statements - Narratives (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:SalesAndExciseTaxPayableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_YJ2u-Jy0BEup-AiC0jf2ug", "name": "vsee:ReversalOfBusinessCombinationAcquisitionRelatedStockBasedCompensationExpenses", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R45": { "role": "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "longName": "99940202 - Disclosure - Restatement of Previously Issued Financial Statements - Effect of the restatement on each financial statement line item (Details)", "shortName": "Restatement of Previously Issued Financial Statements - Effect of the restatement on each financial statement line item (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_9_30_2024_ohHoHauKgEKE25QTyN9_DA", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_3_31_2023_x5cWvStCTUiaKoN1f7C68w", "name": "us-gaap:LiabilitiesCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R46": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "longName": "99940301 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R47": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "longName": "99940302 - Disclosure - Summary of Significant Accounting Policies - Net Loss Per Common Share (Details)", "shortName": "Summary of Significant Accounting Policies - Net Loss Per Common Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_vsee_PublicWarrantsMember_XNdI6wvhfUat4XzTU5Zd0g", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R48": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails", "longName": "99940303 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable and Credit losses (Details)", "shortName": "Summary of Significant Accounting Policies - Accounts Receivable and Credit losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "As_Of_12_31_2023_NdAflNzyIk6WRF-fuppVXA", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_Wy-1ioRen0i7kttAaDw5Lw", "name": "vsee:AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R49": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails", "longName": "99940304 - Disclosure - Summary of Significant Accounting Policies - Deferred Revenue (Details)", "shortName": "Summary of Significant Accounting Policies - Deferred Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_srt_ProductOrServiceAxis_vsee_SubscriptionProfessionalAndTechnicalEngineeringServicesMember_kwJ0UnEp702gMjGmpWiLlw", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "vsee:ContractWithCustomerLiabilityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R50": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails", "longName": "99940305 - Disclosure - Summary of Significant Accounting Policies - Credit Risk and Major Customers/Supplier Concentration (Details)", "shortName": "Summary of Significant Accounting Policies - Credit Risk and Major Customers/Supplier Concentration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_vsee_FiveCustomersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_nHLR-kgDVk2CqWRmr8XY3Q", "name": "vsee:ConcentrationRiskNumberOfCustomers", "unitRef": "Unit_Standard_customer_xRD838zIHkeLx3e_7WzoUg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R51": { "role": "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails", "longName": "99940306 - Disclosure - Summary of Significant Accounting Policies - Acquired Intangible Assets (Details)", "shortName": "Summary of Significant Accounting Policies - Acquired Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R52": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "longName": "99940401 - Disclosure - Business Combination - Purchase Consideration (Details)", "shortName": "Business Combination - Purchase Consideration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_XAM2kqEI006rRSrjj_c5IQ", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_XAM2kqEI006rRSrjj_c5IQ", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R53": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "longName": "99940402 - Disclosure - Business Combination - Preliminary allocation of total purchase consideration (Details)", "shortName": "Business Combination - Preliminary allocation of total purchase consideration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:Goodwill", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_XAM2kqEI006rRSrjj_c5IQ", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R54": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails", "longName": "99940403 - Disclosure - Business Combination - Pro forma Financial Information (Details)", "shortName": "Business Combination - Pro forma Financial Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R55": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "longName": "99940404 - Disclosure - Business Combination - Recapitalization (Details)", "shortName": "Business Combination - Recapitalization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_Wy-1ioRen0i7kttAaDw5Lw", "name": "vsee:EstimatedValueOfSharesAndOptionsGranted", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R56": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "longName": "99940405 - Disclosure - Business Combination - Summary of recapitalization and net equity (Details)", "shortName": "Business Combination - Summary of recapitalization and net equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_24_2024_us-gaap_BusinessAcquisitionAxis_vsee_DigitalHealthAcquisitionCorpMember_OjmadRo380-dVTgiQzWu5A", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R57": { "role": "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "longName": "99940406 - Disclosure - Business Combination - Additional Information (Details)", "shortName": "Business Combination - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:PreferredStockConvertibleConversionPrice", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:PreferredStockConvertibleConversionPrice", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_XAM2kqEI006rRSrjj_c5IQ", "name": "vsee:BusinessAcquisitionEquityInterestIssuableNumberOfShares", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R58": { "role": "http://vseehealth.com/role/DisclosureFixedAssetsDetails", "longName": "99940501 - Disclosure - Fixed Assets (Details)", "shortName": "Fixed Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R59": { "role": "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "longName": "99940601 - Disclosure - Leases - Operating Leases (Details)", "shortName": "Leases - Operating Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "As_Of_12_31_2024_srt_RangeAxis_srt_MinimumMember_gfqeKr5vv0GLYKgCZzzjUQ", "name": "us-gaap:LesseeOperatingLeaseDiscountRate", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_srt_RangeAxis_srt_MinimumMember_gfqeKr5vv0GLYKgCZzzjUQ", "name": "us-gaap:LesseeOperatingLeaseDiscountRate", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R60": { "role": "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails", "longName": "99940602 - Disclosure - Leases - Operating right-of-use assets (Details)", "shortName": "Leases - Operating right-of-use assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "vsee:OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "vsee:OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R61": { "role": "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails", "longName": "99940603 - Disclosure - Leases - Operating lease liabilities (Details)", "shortName": "Leases - Operating lease liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeOperatingLeaseLiabilitiesTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "vsee:OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "vsee:LeaseDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R62": { "role": "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails", "longName": "99940604 - Disclosure - Leases - Operating lease future minimum rent payments (Details)", "shortName": "Leases - Operating lease future minimum rent payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R63": { "role": "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails", "longName": "99940605 - Disclosure - Leases - Operating lease payments (Details)", "shortName": "Leases - Operating lease payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:OperatingLeaseCost", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:OperatingLeaseCost", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R64": { "role": "http://vseehealth.com/role/DisclosureLeasesFinanceLeasesDetails", "longName": "99940606 - Disclosure - Leases - Finance Leases (Details)", "shortName": "Leases - Finance Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "vsee:LesseeFinanceLeaseNumberOfLeases", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "vsee:LesseeFinanceLeaseNumberOfLeases", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R65": { "role": "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails", "longName": "99940607 - Disclosure - Leases - Finance leased equipment (Details)", "shortName": "Leases - Finance leased equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R66": { "role": "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails", "longName": "99940608 - Disclosure - Leases - Finance lease liabilities (Details)", "shortName": "Leases - Finance lease liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FinanceLeasePrincipalPayments", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:FinanceLeasePrincipalPayments", "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R67": { "role": "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseExpensesDetails", "longName": "99940609 - Disclosure - Leases - Finance lease expenses (Details)", "shortName": "Leases - Finance lease expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FinanceLeaseInterestExpense", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "vsee:FinanceLeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R68": { "role": "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails", "longName": "99940610 - Disclosure - Leases - Finance lease future minimum rent payments (Details)", "shortName": "Leases - Finance lease future minimum rent payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R69": { "role": "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseWeightedAverageRemainingLeaseTermAndDiscountRateDetails", "longName": "99940611 - Disclosure - Leases - Finance lease - Weighted average remaining lease term and discount rate (Details)", "shortName": "Leases - Finance lease - Weighted average remaining lease term and discount rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeFinanceLeaseSupplementalInformationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "td", "tr", "table", "vsee:LesseeFinanceLeaseSupplementalInformationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R70": { "role": "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "longName": "99940701 - Disclosure - Accounts Payable and Accrued Liabilities (Details)", "shortName": "Accounts Payable and Accrued Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R71": { "role": "http://vseehealth.com/role/DisclosureFactoringPayableDetails", "longName": "99940801 - Disclosure - Factoring Payable (Details)", "shortName": "Factoring Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:FutureReceiptsSaleAgreementInterestRate", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "vsee:FactoringPayableTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:FutureReceiptsSaleAgreementInterestRate", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "vsee:FactoringPayableTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R72": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "longName": "99940901 - Disclosure - Line of Credit and Notes Payable, Net of Discount (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R73": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails", "longName": "99940902 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Principal Payments (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Principal Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R74": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "longName": "99940903 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Notes Payable (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_11_29_2021_us-gaap_DebtInstrumentAxis_vsee_NotePayableIssuedNovember292021Member_VXzwOBEobUKZDAbLwVscxQ", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R75": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "longName": "99940904 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Line of Credit (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Line of Credit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:LongTermDebt", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_11_29_2021_us-gaap_DebtInstrumentAxis_vsee_LineOfCreditIssuedNovember292021Member_YRf0qSQWeEaSCU0W_8spNA", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R76": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "longName": "99940905 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Loan Conversions (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Loan Conversions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_XAM2kqEI006rRSrjj_c5IQ", "name": "vsee:StockIssuedDuringPeriodSharesDebtSettlement", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_11_1_2023_srt_CounterpartyNameAxis_vsee_MunroTrustMember_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_us-gaap_DebtConversionByUniqueDescriptionAxis_vsee_ConversionSecuritiesPurchaseAgreementsMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_vsee_SponsorAffiliateMember_GKcy_b2C4EmfTV2g2BG5Uw", "name": "vsee:DebtConvertibleOriginalDebtAmount", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R77": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "longName": "99940906 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Exchange Note Exchange Financing (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Exchange Note Exchange Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_bsroNy-GNUaUqlXITRtm2w", "name": "vsee:DebtInstrumentConvertibleMaximumResetOfConversionPrice", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R78": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "longName": "99940907 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Additional Bridge Financing (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Additional Bridge Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_11_21_2023_us-gaap_DebtInstrumentAxis_vsee_AdditionalBridgeNotesMember_0PqWuK1bqkCE9FYvLHTBgg", "name": "vsee:DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R79": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "longName": "99940908 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Extension Note (Extension Financing) (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Extension Note (Extension Financing) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_5_5_2023_us-gaap_DebtInstrumentAxis_vsee_ExtensionNoteMember_gX2sxMuWcUajVq-3BAJ3fA", "name": "vsee:DebtInstrumentPercentageOfOriginalIssueDiscount", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R80": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "longName": "99940909 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Quantum Financing Securities Purchase Agreement (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Quantum Financing Securities Purchase Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_3_2024_To_7_3_2024_us-gaap_DebtInstrumentAxis_vsee_QuantumNoteMember_la4b0TE6akejs9wdpSYSyg", "name": "vsee:DebtInstrumentPeriodOfGuaranteedInterestPayment", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R81": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "longName": "99940910 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Equity Financing (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Equity Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_us-gaap_DebtInstrumentAxis_vsee_EquityLineOfCreditMember_nKhs3Nww7E-iLvamKzuhlg", "name": "vsee:SharesAgreedToBePurchasedPeriod", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R82": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "longName": "99940911 - Disclosure - Line of Credit and Notes Payable, Net of Discount - ELOC Commitment Fee Note (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - ELOC Commitment Fee Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_11_21_2023_us-gaap_DebtInstrumentAxis_vsee_EquityLineOfCreditCommitmentFeeNoteMember_ju9ktnCh9EimxP5kvfqCSA", "name": "vsee:DebtInstrumentPrincipalAmountIssuable", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R83": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "longName": "99940912 - Disclosure - Line of Credit and Notes Payable, Net of Discount - September 2024 Note (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - September 2024 Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_9_30_2024_To_9_30_2024_us-gaap_DebtInstrumentAxis_vsee_September2024ConvertibleNoteMember_IK-o3VABVkOaA6FASujMGA", "name": "us-gaap:ProceedsFromIssuanceOfDebt", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R84": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails", "longName": "99940913 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Underwriters' Agreement (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Underwriters' Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "As_Of_11_21_2023_AaGUfTMll02Y87GtkrcJMA", "name": "vsee:DeferredUnderwritingFee", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_11_21_2023_AaGUfTMll02Y87GtkrcJMA", "name": "vsee:DeferredUnderwritingFee", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R85": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "longName": "99940914 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Simple Agreement for Future Equity (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Simple Agreement for Future Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "As_Of_12_31_2023_NdAflNzyIk6WRF-fuppVXA", "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_8_1_2023_IUUbYyDTIkOk3fQxUVoaHg", "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R86": { "role": "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "longName": "99940915 - Disclosure - Line of Credit and Notes Payable, Net of Discount - Encompass Purchase Liability (Details)", "shortName": "Line of Credit and Notes Payable, Net of Discount - Encompass Purchase Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "vsee:BusinessCombinationPurchaseConsiderationPayableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_1_1_2022_dei_LegalEntityAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_us-gaap_BusinessAcquisitionAxis_vsee_EncompassHealthcareBillingLlcMember_Ve8j8_yuck29gDuvWdevvA", "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R87": { "role": "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "longName": "99941001 - Disclosure - Related Party - Related Party Transactions by VSee Lab (Details)", "shortName": "Related Party - Related Party Transactions by VSee Lab (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_srt_CounterpartyNameAxis_vsee_MiltonChenMember_us-gaap_RelatedPartyTransactionAxis_vsee_RelatedPartyPromissoryNoteOneMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_ChiefExecutiveOfficerMember_qhhDU9t64064MA-nVMFs9w", "name": "us-gaap:LoansPayableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:LoansPayableCurrent", "span", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R88": { "role": "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "longName": "99941002 - Disclosure - Related Party - Related Party Transactions by iDoc (Details)", "shortName": "Related Party - Related Party Transactions by iDoc (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:OtherReceivablesNetCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_InvestorMember_mpwakgo0ek2FgL8LDP3ArQ", "name": "us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R89": { "role": "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "longName": "99941003 - Disclosure - Related Party - Related Party Transactions by VSee Health (f/k/a DHAC) (Details)", "shortName": "Related Party - Related Party Transactions by VSee Health (f/k/a DHAC) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:GeneralAndAdministrativeExpense", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_12_13_2024_To_12_13_2024_srt_CounterpartyNameAxis_vsee_DominionMember_us-gaap_DebtInstrumentAxis_vsee_EquityLineOfCreditCommitmentFeeNoteMember_sticfq5JK0qtX-xwxjsr5Q", "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R90": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesDetails", "longName": "99941101 - Disclosure - Commitments, Contingencies, and Concentration Risk - Contingencies (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk - Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R91": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "longName": "99941102 - Disclosure - Commitments, Contingencies, and Concentration Risk - Contingencies - Robots Purchase Agreement (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk - Contingencies - Robots Purchase Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_InvestorMember_mpwakgo0ek2FgL8LDP3ArQ", "name": "vsee:NumberOfDeployedTelepresenceRobotsRightsHeld", "unitRef": "Unit_Standard_item_1J8ehyTSWE-bHCeFwW34GQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_5_15_2023_To_5_15_2023_srt_ConsolidatedEntitiesAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_us-gaap_InvestorMember_wIyQofmmz0KDyvxUudtzkw", "name": "vsee:NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "unitRef": "Unit_Standard_item_1J8ehyTSWE-bHCeFwW34GQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R92": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "longName": "99941103 - Disclosure - Commitments, Contingencies, and Concentration Risk - Contingencies - Forbearance Agreement (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk - Contingencies - Forbearance Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_1_2023_To_11_1_2023_us-gaap_DebtInstrumentAxis_vsee_PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember_dyHlZ2SEH0u53fBG7UEP6Q", "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R93": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "longName": "99941104 - Disclosure - Commitments, Contingencies, and Concentration Risk - Major Customer Concentration (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk - Major Customer Concentration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_srt_MajorCustomersAxis_vsee_FiveCustomersMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_nHLR-kgDVk2CqWRmr8XY3Q", "name": "vsee:ConcentrationRiskNumberOfCustomers", "unitRef": "Unit_Standard_customer_xRD838zIHkeLx3e_7WzoUg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_srt_MajorCustomersAxis_vsee_OneCustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_2lImtoXbe0606rPIXj2yRA", "name": "vsee:ConcentrationRiskNumberOfCustomers", "unitRef": "Unit_Standard_customer_xRD838zIHkeLx3e_7WzoUg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R94": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "longName": "99941105 - Disclosure - Commitments, Contingencies, and Concentration Risk - Major Vendor Concentration (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk - Major Vendor Concentration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_vsee_OneVendorMember_n8_YLWhgkES5mTWSg7ofJQ", "name": "vsee:ConcentrationRiskNumberOfSuppliers", "unitRef": "Unit_Standard_customer_xRD838zIHkeLx3e_7WzoUg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R95": { "role": "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskOtherMattersDetails", "longName": "99941106 - Disclosure - Commitments, Contingencies, and Concentration Risk - Other Matters (Details)", "shortName": "Commitments, Contingencies, and Concentration Risk - Other Matters (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:SalesAndExciseTaxPayableCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R96": { "role": "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails", "longName": "99941201 - Disclosure - Income Taxes - Schedule of Income tax provision (Details)", "shortName": "Income Taxes - Schedule of Income tax provision (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_NV-ITb6ME0eCUijUDwUS-A", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_NV-ITb6ME0eCUijUDwUS-A", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R97": { "role": "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails", "longName": "99941202 - Disclosure - Income Taxes - Summary of reconciliation of the federal income tax rate to the Company's effective tax rate (Details)", "shortName": "Income Taxes - Summary of reconciliation of the federal income tax rate to the Company's effective tax rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R98": { "role": "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails", "longName": "99941203 - Disclosure - Income Taxes - Deferred tax assets and liabilities (Details)", "shortName": "Income Taxes - Deferred tax assets and liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R99": { "role": "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails", "longName": "99941204 - Disclosure - Income Taxes - Additional Information (Details)", "shortName": "Income Taxes - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R100": { "role": "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "longName": "99941301 - Disclosure - Equity - Preferred Stock (Details)", "shortName": "Equity - Preferred Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_StatementClassOfStockAxis_us-gaap_SeriesAPreferredStockMember_h1oKOJtdlkGG5R5j6wm_4g", "name": "vsee:NumberOfSharesAllocated", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R101": { "role": "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "longName": "99941302 - Disclosure - Equity - Common Stock (Details)", "shortName": "Equity - Common Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_6_24_2024_To_6_24_2024_Wy-1ioRen0i7kttAaDw5Lw", "name": "vsee:ConversionOfStockEquivalentCommonStockSharesUponConversion", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R102": { "role": "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails", "longName": "99941303 - Disclosure - Equity - Stock Options (Details)", "shortName": "Equity - Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R103": { "role": "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "longName": "99941304 - Disclosure - Equity - Key assumptions used in valuing the unvested options (Details)", "shortName": "Equity - Key assumptions used in valuing the unvested options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:SharePrice", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:SharePrice", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R104": { "role": "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "longName": "99941305 - Disclosure - Equity - Common Stock Issuance Obligation (Details)", "shortName": "Equity - Common Stock Issuance Obligation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "As_Of_6_30_2024_N-abfIQmNkiL34DzR-EXFw", "name": "vsee:CommonStockIssuanceObligationCurrent", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_AwardTypeAxis_vsee_CommonStockIssuanceObligationMember_us-gaap_BusinessAcquisitionAxis_vsee_IdocVirtualTelehealthSolutionsIncMember_sTinHPrm20WnxT1F5C61ew", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R105": { "role": "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails", "longName": "99941401 - Disclosure - Warrants - Warrants issued and outstanding (Details)", "shortName": "Warrants - Warrants issued and outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:ClassOfWarrantOrRightAssumed", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:ClassOfWarrantOrRightAssumed", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R106": { "role": "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "longName": "99941402 - Disclosure - Warrants - Public and Private Warrants (Details)", "shortName": "Warrants - Public and Private Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_ClassOfWarrantOrRightAxis_vsee_PublicAndPrivateWarrantsMember_EtVMBNM-Q0SfzuTnDjLf7g", "name": "vsee:ClassOfWarrantOrRightIssued", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R107": { "role": "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "longName": "99941403 - Disclosure - Warrants - Bridge, Extension and September 2024 Warrants (Details)", "shortName": "Warrants - Bridge, Extension and September 2024 Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:ClassOfWarrantOrRightIssuedDuringPeriod", "unitRef": "Unit_Standard_shares_80AneEr30UKcLw6BvEbAFA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_10_6_2022_us-gaap_ClassOfWarrantOrRightAxis_vsee_BridgeWarrantsMember_mlU5jPZcekKzzPTTob48sA", "name": "us-gaap:WarrantsAndRightsOutstandingTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R108": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsDetails", "longName": "99941501 - Disclosure - Reportable Segments (Details)", "shortName": "Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "Unit_Standard_segment_f-rQplZ2HU6lG29Lb1zDkA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "vsee:NumberOfLegacyOperatingEntities", "unitRef": "Unit_Standard_item_1J8ehyTSWE-bHCeFwW34GQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R109": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "longName": "99941502 - Disclosure - Reportable Segments - Reconciliation of consolidated segment (Details)", "shortName": "Reportable Segments - Reconciliation of consolidated segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_ZUYUckzqeU-pGJP34AGPdQ", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R110": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails", "longName": "99941503 - Disclosure - Reportable Segments - Total Assets by Segment (Details)", "shortName": "Reportable Segments - Total Assets by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:Assets", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_vsee_TechnologySegmentMember_Jy0IvMpYGUafrOTAVJCVkg", "name": "us-gaap:Assets", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R111": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "longName": "99941504 - Disclosure - Reportable Segments - Depreciation and Amortization by Segment (Details)", "shortName": "Reportable Segments - Depreciation and Amortization by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_StatementBusinessSegmentsAxis_vsee_TechnologySegmentMember_Ajf59pSf3kmyPwG2HsoxhQ", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } }, "R112": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "longName": "99941505 - Disclosure - Reportable Segments - Capital Expenditures by Segment (Details)", "shortName": "Reportable Segments - Capital Expenditures by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:PaymentsToAcquireProductiveAssets", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:PaymentsToAcquireProductiveAssets", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R113": { "role": "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "longName": "99941506 - Disclosure - Reportable Segments - Interest Expense by Segment (Details)", "shortName": "Reportable Segments - Interest Expense by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "Duration_7_1_2024_To_9_30_2024_LCmRhTpJbUSNsLVUM2YlFA", "name": "us-gaap:InterestExpenseNonoperating", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": null }, "R114": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "longName": "99941601 - Disclosure - Fair Value Measurements - Fair value information (Details)", "shortName": "Fair Value Measurements - Fair value information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_vsee_ExchangeNotesMember_2sONBRjwRUewFjU3ZHyjAA", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_vsee_ExchangeNotesMember_2sONBRjwRUewFjU3ZHyjAA", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R115": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "longName": "99941602 - Disclosure - Fair Value Measurements - Measurement - Quantum Convertible Note (Details)", "shortName": "Fair Value Measurements - Measurement - Quantum Convertible Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_DebtInstrumentAxis_vsee_QuantumNoteMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_gVqLdb3s0UGFI8ZBNpssfg", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_DebtInstrumentAxis_vsee_QuantumNoteMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_gVqLdb3s0UGFI8ZBNpssfg", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R116": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "longName": "99941603 - Disclosure - Fair Value Measurements - Measurement - Extension Note - Bifurcated Derivative (Details)", "shortName": "Fair Value Measurements - Measurement - Extension Note - Bifurcated Derivative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "As_Of_6_24_2024_us-gaap_FinancialInstrumentAxis_vsee_ExtensionNoteBifurcatedDerivativeMember_us-gaap_MeasurementInputTypeAxis_vsee_MeasurementInputCccBondRateMember_5ISpFE6USEiVErKMgPI8Vg", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_24_2024_us-gaap_FinancialInstrumentAxis_vsee_ExtensionNoteBifurcatedDerivativeMember_us-gaap_MeasurementInputTypeAxis_vsee_MeasurementInputCccBondRateMember_5ISpFE6USEiVErKMgPI8Vg", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R117": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "longName": "99941604 - Disclosure - Fair Value Measurements - Measurement - Additional Bridge Note (Details)", "shortName": "Fair Value Measurements - Measurement - Additional Bridge Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "As_Of_11_26_2024_us-gaap_DebtInstrumentAxis_vsee_AdditionalBridgeNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_MnCojqkFLUmzza1fb-8ySg", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_11_26_2024_us-gaap_DebtInstrumentAxis_vsee_AdditionalBridgeNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_MnCojqkFLUmzza1fb-8ySg", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R118": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "longName": "99941605 - Disclosure - Fair Value Measurements - Measurement - Exchange Note (Details)", "shortName": "Fair Value Measurements - Measurement - Exchange Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_DebtInstrumentAxis_vsee_ExchangeNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_ldlC0RmpikinPbK8etJFgw", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_DebtInstrumentAxis_vsee_ExchangeNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_ldlC0RmpikinPbK8etJFgw", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R119": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "longName": "99941606 - Disclosure - Fair Value Measurements - Measurement - Equity Line of Credit (Details)", "shortName": "Fair Value Measurements - Measurement - Equity Line of Credit (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_FinancialInstrumentAxis_vsee_EquityLineOfCreditMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_7oel21-_DEqjDOAuJ2p1Pg", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2024_us-gaap_FinancialInstrumentAxis_vsee_EquityLineOfCreditMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_7oel21-_DEqjDOAuJ2p1Pg", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R120": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "longName": "99941607 - Disclosure - Fair Value Measurements - Measurement - ELOC Commitment Fee Note (Details)", "shortName": "Fair Value Measurements - Measurement - ELOC Commitment Fee Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "As_Of_7_2_2024_us-gaap_FinancialInstrumentAxis_vsee_EquityLineOfCreditCommitmentFeeNoteMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_f3OJ5tkH_0mvcZYJfLPQMQ", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_7_2_2024_us-gaap_FinancialInstrumentAxis_vsee_EquityLineOfCreditCommitmentFeeNoteMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_f3OJ5tkH_0mvcZYJfLPQMQ", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R121": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails", "longName": "99941608 - Disclosure - Fair Value Measurements - Measurement - September 2024 Convertible Note (Details)", "shortName": "Fair Value Measurements - Measurement - September 2024 Convertible Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_DebtInstrumentAxis_vsee_September2024ConvertibleNoteMember_sbQSb4dtjUydbVuZE-XTjw", "name": "vsee:DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_us-gaap_DebtInstrumentAxis_vsee_September2024ConvertibleNoteMember_sbQSb4dtjUydbVuZE-XTjw", "name": "vsee:DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault", "unitRef": "Unit_Standard_pure_-zooQR0f7kadPskv8xsShA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R122": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "longName": "99941609 - Disclosure - Fair Value Measurements - Changes in the fair value of financial liabilities (Details)", "shortName": "Fair Value Measurements - Changes in the fair value of financial liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_24_2024_1sxKVJXJ4UiajFOMEHJtsA", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R123": { "role": "http://vseehealth.com/role/DisclosureFairValueMeasurementsTransfersDetails", "longName": "99941610 - Disclosure - Fair Value Measurements - Transfers (Details)", "shortName": "Fair Value Measurements - Transfers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2024_To_12_31_2024_aZIyf42THUOsIDJ4kuR_Vw", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true, "unique": true } }, "R124": { "role": "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "longName": "99941701 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "As_Of_12_31_2024_lfAgGmLhT0eRTzIxB1e1kg", "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "unitRef": "Unit_Divide_USD_shares_Ww6WUzx6KECdtPr5jc4Lig", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "us-gaap:DebtInstrumentConvertibleConversionPrice1", "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_3_20_2025_To_3_20_2025_us-gaap_DebtInstrumentAxis_vsee_SecuredPromissoryNoteIssuedOnMarch202025Member_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_FrCCdc6bVkemrImmO3ZTww", "name": "us-gaap:ProceedsFromNotesPayable", "unitRef": "Unit_Standard_USD_RKGCpjjIKEy_jk5lXZUXDQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee-20241231x10k.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 }, "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued liabilities", "totalLabel": "Total accounts payable and accrued liabilities", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r96", "r97" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accounts Payable and Accrued Liabilities", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r95", "r97", "r101", "r1244" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndAccruedLiabilitiesMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities [Member]", "terseLabel": "Accounts payable and accrued liabilities", "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r95", "r976" ] }, "vsee_AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable raised from business acquisition.", "label": "Accounts Receivable, Allowance for Credit Loss Increase From Acquisition", "verboseLabel": "Allowance for credit losses, due to acquisition" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "terseLabel": "Schedule of allowance for credit losses", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r1185" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "terseLabel": "Accounts receivable", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r903" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for credit losses of $2,393,033 and $32,457 as of December 31, 2024 and 2023, respectively", "verboseLabel": "Accounts receivable, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1173" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes, Current", "terseLabel": "Income tax payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r97", "r161" ] }, "vsee_AccruedLiabilitiesCommonStockIssuableToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AccruedLiabilitiesCommonStockIssuableToRelatedParty", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date relating to future stock issuances to the related party as part of the consulting agreement.", "label": "Accrued Liabilities, Common Stock Issuable To Related Party", "terseLabel": "Stock issuances to the related party" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureFixedAssetsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r50", "r203", "r752" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r380", "r381", "r382", "r384", "r916" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r1055" ] }, "vsee_AdditionalBridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AdditionalBridgeNotesMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to additional bridge note.", "label": "Additional Bridge Notes [Member]", "terseLabel": "Additional Bridge Notes" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r108", "r976", "r1328" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r810", "r1156", "r1157", "r1158", "r1161", "r1259", "r1329" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r1068" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r1068" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r1068" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r1068" ] }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsForErrorCorrectionDomain", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Error Correction, Type [Domain]", "documentation": "Type of error correction." } } }, "auth_ref": [ "r245", "r246", "r247", "r252", "r253", "r254", "r255" ] }, "vsee_AdjustmentsToAdditionalPaidInCapitalConversionOfDebtGainLossOnRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AdjustmentsToAdditionalPaidInCapitalConversionOfDebtGainLossOnRestructuring", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in adjustments to additional paid-in capital (APIC) resulting from the gain (loss) on restructuring.", "label": "Adjustments to Additional paid-in Capital, Conversion of Debt, Gain (Loss) on Restructuring", "terseLabel": "Additional reduction in the carrying value representing as gain on restructuring" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "vsee_AdministratorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AdministratorMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to administrator.", "label": "Administrator [Member]", "terseLabel": "Office expense" } } }, "auth_ref": [] }, "vsee_AffiliateOfSponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AffiliateOfSponsorMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for an affiliate of the sponsor.", "label": "Affiliate Of The Sponsor [Member]", "terseLabel": "Affiliate Of The Sponsor" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r1113" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1026", "r1037", "r1047", "r1080" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r1029", "r1040", "r1050", "r1083" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r1114" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r1068" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r1075" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1075", "r1084", "r1088", "r1096" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r1094" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Share-based compensation expense", "verboseLabel": "Stock-based compensation", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r523", "r528" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Ending allowance for credit losses", "periodStartLabel": "Beginning allowance for credit losses", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r212", "r315", "r351", "r354", "r357", "r1296" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for credit losses", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r212", "r315", "r351" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Less accounts receivable write-off included in allowance for credit losses above", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r356" ] }, "vsee_AmendedAndRestatedConversionSecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AmendedAndRestatedConversionSecuritiesPurchaseAgreementsMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to amended and restated conversion conversion securities purchase agreement.", "label": "Amended And Restated Conversion Securities Purchase Agreements [Member]", "terseLabel": "Amended and Restated Conversion SPAs" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of discount on note payable", "verboseLabel": "Amortized debt discount", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r4", "r121", "r442", "r1274" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r4", "r379", "r386", "r942" ] }, "vsee_AmortizationOfRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AmortizationOfRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset.", "label": "Amortization of Right of Use Asset", "terseLabel": "Amortization of right-of-use assets" } } }, "auth_ref": [] }, "vsee_AmountPaidByInvestor": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "AmountPaidByInvestor", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount paid by an accredited investor in a partnership agreement with the company.", "label": "Amount Paid By Investor", "terseLabel": "Amount paid by investor" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive shares outstanding", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r265" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r32" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Net Loss Per Common Share", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r32" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r159", "r174", "r206", "r232", "r268", "r276", "r301", "r305", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r578", "r582", "r620", "r741", "r847", "r933", "r934", "r976", "r1005", "r1207", "r1208", "r1285" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "terseLabel": "Total current assets", "totalLabel": "Total current assets", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r199", "r213", "r232", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r578", "r582", "r620", "r976", "r1207", "r1208", "r1285" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorFirmId", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r1009", "r1010", "r1033" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorLocation", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r1009", "r1010", "r1033" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditorName", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r1009", "r1010", "r1033" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r1091" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r1092" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r1087" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r1087" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r1087" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r1087" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r1087" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r1087" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r494", "r495", "r496", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r518", "r519", "r520", "r521", "r522" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r1090" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1089" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r1088" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r1088" ] }, "vsee_BridgeExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BridgeExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to bridge exchange agreement.", "label": "Bridge Exchange Agreement [Member]", "terseLabel": "Bridge Exchange Agreement" } } }, "auth_ref": [] }, "vsee_BridgeInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BridgeInvestorMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Bridge Investor.", "label": "Bridge Investor [Member]", "terseLabel": "Bridge Investor" } } }, "auth_ref": [] }, "vsee_BridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BridgeNotesMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to the bridge notes issued by the entity.", "label": "Bridge Notes [Member]", "terseLabel": "Bridge Note" } } }, "auth_ref": [] }, "vsee_BridgeSecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BridgeSecuritiesPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "It represents bridge securities purchase agreement.", "label": "Bridge Securities Purchase Agreement [Member]", "terseLabel": "Bridge securities purchase agreement" } } }, "auth_ref": [] }, "vsee_BridgeWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BridgeWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Bridge Warrants.", "label": "Bridge Warrants [Member]", "terseLabel": "Bridge Warrants" } } }, "auth_ref": [] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BuildingMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "terseLabel": "Building", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r133" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationTables", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r380", "r381", "r382", "r383", "r384", "r570", "r955", "r956" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationTables", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r68", "r71", "r380", "r381", "r382", "r383", "r384", "r570", "r955", "r956" ] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Common Stock Issued or Issuable, Number of Shares", "terseLabel": "Number of shares of common stock issued to seller" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionNumberOfShares", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares of equity interests issued or issuable upon debt conversion to acquire entity.", "label": "Business Acquisition, Common Stock Issued or Issuable Upon Debt Conversion, Number of Shares", "terseLabel": "Number of shares of common stock issued upon conversion of debt" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock issued or issuable upon debt conversion in consideration for the business combination.", "label": "Business Acquisition, Common Stock Issued or Issuable Upon Debt Conversion, Value Assigned", "terseLabel": "Shares of common stock issued upon conversion of debt at $12.11 per share" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock issued or issuable in consideration for the business combination.", "label": "Business Acquisition, Common Stock Issued or Issuable, Value Assigned", "terseLabel": "4,950,000 shares of common stock issued to sellers at $12.11 per share" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionEquityInterestConvertedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionEquityInterestConvertedValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) converted to acquire the entity.", "label": "Business Acquisition, Equity Interest Converted, Value", "terseLabel": "Notes converted" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionEquityInterestIssuableNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionEquityInterestIssuableNumberOfShares", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issuable, Number of Shares", "terseLabel": "Equity interests issuable" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "verboseLabel": "Total purchase consideration", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity." } } }, "auth_ref": [ "r154" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Number of shares issued for business combination (in shares)", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r154" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationTables", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "terseLabel": "Business Combination", "verboseLabel": "Organization and Description of Business", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r570" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Business acquisition percentage of voting interests acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r69" ] }, "vsee_BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionSharesAssigned": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionSharesAssigned", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Shares of preferred stock issued or issuable to acquire the entity.", "label": "Business Acquisition Preferred Stock Issued Or Issuable Upon Debt Conversion Shares Assigned", "terseLabel": "Common stock issuable upon conversion" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of preferred stock issued or issuable upon debt conversion in consideration for the business combination.", "label": "Business Acquisition, Preferred Stock Issued or Issuable Upon Debt Conversion, Value Assigned", "terseLabel": "150,000 shares of preferred stock issued upon conversion of debt at $12.11 per share" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaAmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionProFormaAmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The pro forma amortization of intangible assets for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Amortization Of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic", "terseLabel": "Net loss per share, basic", "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r1126", "r1127" ] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted", "terseLabel": "Net loss per share, diluted", "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r1126", "r1127" ] }, "us-gaap_BusinessAcquisitionProFormaInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaInformationAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information [Abstract]", "terseLabel": "Pro Forma Information" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaInformationAdjustmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionProFormaInformationAdjustmentsAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information, Adjustments [Abstract]", "terseLabel": "Pro Forma Adjustments" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Summary of pro forma financial information", "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate." } } }, "auth_ref": [ "r1126", "r1127" ] }, "vsee_BusinessAcquisitionProFormaTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionProFormaTransactionExpenses", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The pro forma transaction expenses for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Transaction Expenses", "terseLabel": "Transaction expenses" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The pro forma basic weighted average shares outstanding for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Weighted Average Shares Outstanding, Basic", "terseLabel": "Weighted average shares, basic" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The pro forma diluted weighted average shares outstanding for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Weighted Average Shares Outstanding, Diluted", "terseLabel": "Weighted average shares, diluted" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Share Price", "terseLabel": "Share price per share", "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net loss", "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period." } } }, "auth_ref": [ "r568", "r569" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationProFormaFinancialInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Total revenues", "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period." } } }, "auth_ref": [ "r568", "r569" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Transaction expenses", "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities." } } }, "auth_ref": [ "r67" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred", "terseLabel": "Total purchase price consideration, net of cash acquired of $29,123", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r9" ] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Aggregate principal amount of outstanding notes", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r0", "r1", "r77", "r573" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability", "verboseLabel": "Interest expense", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r78", "r153", "r574", "r599", "r600", "r601" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Contingent liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r78", "r153" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombination" ], "lang": { "en-us": { "role": { "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r146", "r571" ] }, "vsee_BusinessCombinationNotesAssumedFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationNotesAssumedFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value of notes payable assumed which have been recognized as of the acquisition date.", "label": "Business Combination, Notes Assumed, Fair Value", "terseLabel": "Aggregate fair value of notes" } } }, "auth_ref": [] }, "vsee_BusinessCombinationNumberOfSharesCalledByEachRightsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationNumberOfSharesCalledByEachRightsIssued", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of shares or fractional shares that each right entitles the holder, issued pursuant to business combination transaction.", "label": "Business Combination, Number Of Shares Called By Each Rights Issued", "terseLabel": "Number of shares of common stock called by each rights issued" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "terseLabel": "Net loss since the date of acquisition", "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r70" ] }, "vsee_BusinessCombinationProFormaInformationGoodwillImpairmentChargeOfAcquireeActual": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationProFormaInformationGoodwillImpairmentChargeOfAcquireeActual", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "This element represents the amount of goodwill impairment of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Goodwill Impairment Charge of Acquiree, Actual", "terseLabel": "Goodwill impairment since the date of acquisition" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Revenue since the date of acquisition", "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period." } } }, "auth_ref": [ "r70" ] }, "vsee_BusinessCombinationPurchaseConsiderationPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationPurchaseConsiderationPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of business combination purchase consideration due within one year or the operating cycle.", "label": "Business Combination, Purchase Consideration Payable, Current", "terseLabel": "Encompass Purchase liability" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedFinanceLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedFinanceLeaseObligation", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of finance lease obligation assumed in business combination.", "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Finance Lease Obligation", "terseLabel": "Lease liabilities - finance" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of operating lease obligation assumed in business combination.", "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Obligation", "terseLabel": "Lease liabilities - operating" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Estimated fair value of assets acquired:" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash - Trust and cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r73" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of accounts receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Accounts Receivables", "terseLabel": "Accounts receivable, net" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of gross accounts receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Accounts Receivables, Gross", "terseLabel": "Gross contractual accounts receivable" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesNotExpectedToBeCollected": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesNotExpectedToBeCollected", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of gross accounts receivables that are not expected to be collected from customers.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Accounts Receivables Not Expected To Be Collected", "terseLabel": "Gross contractual accounts receivable not expected to be collected" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivables", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of notes receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Notes Receivables", "terseLabel": "Note receivable, related party" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesFromRelatedParties", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables from Related Parties", "terseLabel": "Due from related party" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, accrued liabilities and other liabilities, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable, Accrued Liabilities and Other Liabilities", "terseLabel": "Accounts payable, accrued expenses and other current liabilities" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expenses of taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. used in an entity's business assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses", "negatedLabel": "Accrued Expenses" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of derivative liability due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Derivative Liability", "negatedLabel": "Extension Note - Embedded Derivative" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of exchange notes payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Exchange Notes Payable", "negatedLabel": "Exchange Note" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of line of credit payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Line Of Credit", "negatedLabel": "ELOC" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of extension notes payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Extension Loan", "negatedLabel": "Promissory Note - Extension Note" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of notes payables to the related party due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Other", "negatedLabel": "Promissory Note - SCS Capital Partners LLC" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of notes payables to the sponsor due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Sponsor", "negatedLabel": "Promissory Note - Related Party" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedLabel": "Due to Sponsor", "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of notes payable related to additional bridge loans due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Promissory Notes Payable Additional Bridge Loans", "negatedLabel": "Additional Bridge Notes" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEmployeeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEmployeeLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of employee liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Employee Liability", "terseLabel": "Employee liabilities" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Other intangible assets", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r72", "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0, "order": 1.0 }, "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total liabilities assumed", "terseLabel": "Net liabilities", "totalLabel": "Total liabilities assumed", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Estimated fair value of liabilities assumed:", "verboseLabel": "Liabilities assumed" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Net liabilities acquired", "totalLabel": "Net liabilities assumed", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r72", "r73" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred offering costs due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Deferred Offering Costs", "negatedLabel": "Deferred Underwriting Fee Payable" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt", "terseLabel": "Line of credit and notes payable", "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment", "verboseLabel": "Fixed assets", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r72", "r73" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails": { "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of right of use assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right of Use Assets", "terseLabel": "Right-of-use assets" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage", "terseLabel": "Percentage of equity interest to obtain in acquisition", "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combination" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Transaction Expenses", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r147", "r148", "r149", "r150" ] }, "us-gaap_CapitalLeaseObligationsIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalLeaseObligationsIncurred", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Lease Obligation Incurred", "terseLabel": "Finance lease payable reclassed from financing activities to accounts payable", "documentation": "Amount of increase in lease obligation from new lease." } } }, "auth_ref": [ "r26", "r27" ] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Acquired from Acquisition", "terseLabel": "Cash acquired in Business Combination - iDoc", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r20" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r24", "r201", "r920" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r25" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH, END OF YEAR", "periodStartLabel": "Cash, Beginning of Year", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r125", "r228" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET CHANGE IN CASH", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r125" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r1143", "r1295" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r1066" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "CEO" } } }, "auth_ref": [ "r1172" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r1063" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r1061" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DocumentDocumentAndEntityInformation", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r193", "r209", "r210", "r211", "r232", "r259", "r260", "r262", "r264", "r270", "r271", "r346", "r409", "r412", "r413", "r414", "r418", "r419", "r452", "r453", "r457", "r460", "r467", "r620", "r799", "r800", "r801", "r802", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r835", "r856", "r878", "r895", "r896", "r897", "r898", "r899", "r1119", "r1151", "r1162" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "terseLabel": "Equity", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r209", "r210", "r211", "r270", "r452", "r453", "r455", "r457", "r460", "r465", "r467", "r799", "r800", "r801", "r802", "r948", "r1119", "r1151" ] }, "vsee_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnGreaterOfMarketValueAndNewlyShareIssuedPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnGreaterOfMarketValueAndNewlyShareIssuedPrice", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of adjustment to exercise price of warrants based on the greater of market value and newly issued share price.", "label": "Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Greater Of Market Value And Newly Share Issued Price", "terseLabel": "Adjustment percentage of Exercise price of warrants" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketPrice", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of adjustment to redemption price of warrants or rights based on market value.", "label": "Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Price", "terseLabel": "Adjustment percentage of Redemption price of warrants" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightAssumed": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightAssumed", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights assumed during the period.", "label": "Class of Warrant or Right, Assumed", "terseLabel": "Assumed at June 24, 2024" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r64" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Weighted Average Exercise Price", "verboseLabel": "Exercise price of warrants (in dollars per share)", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r468" ] }, "vsee_ClassOfWarrantOrRightIssued": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightIssued", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights issued.", "label": "Class Of Warrant Or Right Issued", "terseLabel": "Warrants Issued" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightIssuedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightIssuedDuringPeriod", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights issued during the period.", "label": "Class Of Warrant Or Right Issued During Period", "terseLabel": "Warrants issued during period", "verboseLabel": "Issued" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Warrants", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares of common stock per warrant or right", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrants to purchase common stock (in shares)", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r468" ] }, "vsee_ClassOfWarrantOrRightNumberOfTradingDaysConsideredForDeterminationOfFairMarketValue": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightNumberOfTradingDaysConsideredForDeterminationOfFairMarketValue", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of trading days over which average reported last sale price of the shares of common stock is considered for determination of Fair Market Value of warrants.", "label": "Class Of Warrant Or Right, Number Of Trading Days Considered For Determination Of Fair Market Value", "terseLabel": "Number of trading days considered for determination of Fair Market Value of warrants" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding/Exercisable, December 31, 2024", "periodStartLabel": "Outstanding, December 31, 2023", "terseLabel": "Warrants Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for triggering redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Stock Price Trigger", "terseLabel": "Stock price trigger for redemption of Warrants" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold consecutive trading days over which the stock price is considered for redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days considered for redemption of Warrants" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold trading days over which the stock price is considered for redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days", "terseLabel": "Threshold trading days considered for redemption of Warrants" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ClassOfWarrantOrRightRedemptionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The redemption price of class of warrant or rights.", "label": "Class Of Warrant Or Right Redemption Price", "terseLabel": "Redemption price of warrants" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame." } } }, "auth_ref": [ "r64" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1067" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r1067" ] }, "vsee_CommitmentFeeAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommitmentFeeAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of commitment fee expensed during the reporting period.", "label": "Commitment Fee Amount", "terseLabel": "Commitment fee" } } }, "auth_ref": [] }, "vsee_CommitmentFeePayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommitmentFeePayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of fee payable for prior commitments.", "label": "Commitment Fee Payable", "terseLabel": "Commitment fee payable" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments, Contingencies, and Concentration Risk (Note 11)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r102", "r165", "r744", "r834" ] }, "vsee_CommitmentsContingenciesAndConcentrationRiskDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommitmentsContingenciesAndConcentrationRiskDisclosureAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Commitments, Contingencies, and Concentration Risk" } } }, "auth_ref": [] }, "vsee_CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRisk" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies and concentration of risks.", "label": "Commitments, Contingencies and Concentration Risk Disclosure [Text Block]", "terseLabel": "Commitments, Contingencies, and Concentration Risk" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Common stock shares", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r107" ] }, "vsee_CommonStockIssuanceObligationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommonStockIssuanceObligationCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of common stock issuance obligation within one year or the operating cycle if longer, net of discount.", "label": "Common Stock Issuance Obligation, Current", "terseLabel": "Common stock issuance obligation" } } }, "auth_ref": [] }, "vsee_CommonStockIssuanceObligationMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommonStockIssuanceObligationMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to common stock issuance obligation.", "label": "Common Stock Issuance Obligation [Member]", "terseLabel": "Common stock issuance obligation" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r995", "r996", "r997", "r999", "r1000", "r1001", "r1002", "r1156", "r1157", "r1161", "r1259", "r1326", "r1329" ] }, "vsee_CommonStockNumberOfSharesOwned": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommonStockNumberOfSharesOwned", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock owned by the holder as of the reporting date.", "label": "Common Stock, Number Of Shares Owned", "terseLabel": "Number of shares of common stock owned by the holder" } } }, "auth_ref": [] }, "vsee_CommonStockNumberOfVotesPerShare": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommonStockNumberOfVotesPerShare", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of votes that each common share is entitled.", "label": "Common Stock Number Of Votes Per Share", "terseLabel": "Common stock, votes per share" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)", "verboseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r107" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r107", "r835" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r107" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Common stock outstanding immediately following the closing of the Business Combination", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r13", "r107", "r835", "r853", "r1329", "r1330" ] }, "vsee_CommonStockSharesSubscribedAndIssuable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "CommonStockSharesSubscribedAndIssuable", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of common stock shares subscribed and issuable.", "label": "Common Stock, Shares Subscribed and Issuable", "terseLabel": "Employee subscription of shares (in shares)" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 100,000,000 shares authorized 16,297,190 and 4,639,643 shares issued and outstanding as of December 31, 2024 and 2023, respectively", "verboseLabel": "Common stock, value issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r107", "r746", "r976" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r1072" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r1071" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r1073" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r1070" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "auth_ref": [] }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r35", "r36", "r87", "r88", "r313", "r903" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r35", "r36", "r87", "r88", "r313", "r793", "r903" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r35", "r36", "r87", "r88", "r313", "r903", "r1125" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Credit Risk and Major Customers/Supplier Concentration", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r93", "r182" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Line Items]", "terseLabel": "Commitments, Contingencies, and Concentration Risk", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r903" ] }, "vsee_ConcentrationRiskNumberOfCustomers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ConcentrationRiskNumberOfCustomers", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "documentation": "The total number of customers representing the concentration risk for the requisite benchmark.", "label": "Concentration Risk, Number Of Customers", "terseLabel": "Number of customers" } } }, "auth_ref": [] }, "vsee_ConcentrationRiskNumberOfSuppliers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ConcentrationRiskNumberOfSuppliers", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "documentation": "The total number of suppliers representing the concentration risk for the requisite benchmark.", "label": "Concentration Risk, Number Of Suppliers", "terseLabel": "Number of suppliers" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage (in %)", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r35", "r36", "r87", "r88", "r313" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTable", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk [Table]", "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk." } } }, "auth_ref": [ "r34", "r35", "r36", "r37", "r87", "r158", "r903" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r35", "r36", "r87", "r88", "r313", "r903" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r239", "r578", "r579", "r582", "r583", "r660", "r908", "r1206", "r1209", "r1210" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r239", "r578", "r579", "r582", "r583", "r660", "r908", "r1206", "r1209", "r1210" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsAxis", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r172", "r239", "r268", "r278", "r299", "r300", "r301", "r302", "r303", "r305", "r306", "r307", "r409", "r410", "r411", "r412", "r414", "r415", "r416", "r417", "r418", "r933", "r934", "r1207", "r1208" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ConsolidationItemsDomain", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r172", "r239", "r268", "r278", "r299", "r300", "r301", "r302", "r303", "r305", "r306", "r307", "r409", "r410", "r411", "r412", "r414", "r415", "r416", "r417", "r418", "r933", "r934", "r1207", "r1208" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r470", "r471", "r482" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Deferred revenue, net of current portion", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r470", "r471", "r482" ] }, "vsee_ContractWithCustomerLiabilityPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ContractWithCustomerLiabilityPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for contract with customer liability.", "label": "Contract With Customer Liability, Policy [Policy Text Block]", "terseLabel": "Deferred Revenue" } } }, "auth_ref": [] }, "vsee_ConversionOfStockEquivalentCommonStockSharesUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ConversionOfStockEquivalentCommonStockSharesUponConversion", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of common stock shares equivalent to the shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion Of Stock, Equivalent Common Stock Shares Upon Conversion", "terseLabel": "Conversion of stock, equivalent common stock shares upon conversion" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Shares Converted", "terseLabel": "Conversion of stock", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock, Shares Issued", "terseLabel": "Conversion of shares issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "vsee_ConversionSecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ConversionSecuritiesPurchaseAgreementsMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to conversion securities purchase agreement.", "label": "Conversion Securities Purchase Agreements [Member]", "terseLabel": "Conversion SPA" } } }, "auth_ref": [] }, "vsee_ConvertiblePromissoryNoteIssuedOnMarch202025Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ConvertiblePromissoryNoteIssuedOnMarch202025Member", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to convertible promissory note issued March 20, 2025.", "label": "Convertible Promissory Note Issued on March 20, 2025 [Member]", "terseLabel": "Convertible promissory note issued on March 20, 2025" } } }, "auth_ref": [] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CorporateNonSegmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "terseLabel": "Corporate, non-segment", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r17", "r300", "r301", "r302", "r303", "r306", "r1167" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of revenue", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r115", "r116", "r701" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Revenue", "terseLabel": "Cost of revenues", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r117", "r232", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r620", "r933", "r1207" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Cost of Revenue", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r1135" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CounterpartyNameAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r236", "r237", "r424", "r455", "r658", "r680", "r740", "r921", "r923" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit)", "totalLabel": "Total current provision (benefit)", "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1134" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Current provision (benefit):" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "verboseLabel": "Federal", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1134", "r1154", "r1254" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Current State and Local Tax Expense (Benefit)", "verboseLabel": "State", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1134", "r1154", "r1254" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "terseLabel": "Major Customer Concentration Risk", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r131", "r313" ] }, "us-gaap_CustomerListsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerListsMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer Lists [Member]", "terseLabel": "Customer list, net", "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information." } } }, "auth_ref": [ "r75", "r1189", "r1190", "r1191", "r1192", "r1193", "r1195", "r1198", "r1199" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerRelationshipsMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r76", "r1189", "r1190", "r1191", "r1192", "r1193", "r1195", "r1198", "r1199" ] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r1018", "r1107" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r1018", "r1107" ] }, "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]" } } }, "auth_ref": [ "r1020", "r1109" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]" } } }, "auth_ref": [ "r1020", "r1109" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]" } } }, "auth_ref": [ "r1022", "r1111" ] }, "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r1020", "r1109" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r1013", "r1102" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r1014", "r1103" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r1014", "r1103" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r1012", "r1101" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]" } } }, "auth_ref": [ "r1012", "r1101" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]" } } }, "auth_ref": [ "r1012", "r1101" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r1015", "r1104" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r1017", "r1106" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]" } } }, "auth_ref": [ "r1017", "r1106" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r1018", "r1107" ] }, "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]" } } }, "auth_ref": [ "r1021", "r1110" ] }, "cyd_CybersecurityRiskRoleOfManagementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskRoleOfManagementTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Role of Management [Text Block]" } } }, "auth_ref": [ "r1019", "r1108" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r1016", "r1105" ] }, "vsee_DavidL.WickershamMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DavidL.WickershamMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to board of directors of David L. Wickersham.", "label": "David L. Wickersham [Member]", "terseLabel": "David L. Wickersham" } } }, "auth_ref": [] }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionByUniqueDescriptionAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion Description [Axis]", "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction." } } }, "auth_ref": [ "r26", "r28" ] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Shares issued to VSee debt holders for debt conversion", "verboseLabel": "Shares issued as conversion of debt", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r28" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Number of shares issued on conversion of debt", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r26", "r28" ] }, "us-gaap_DebtConversionNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Name [Domain]", "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r28" ] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Debt conversion, amount", "verboseLabel": "Principal amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r26", "r28" ] }, "vsee_DebtConversionOriginalDebtFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtConversionOriginalDebtFairValueAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value of the original debt that is being converted in a noncash or part noncash transaction on the conversion date.", "label": "Debt Conversion, Original Debt, Fair Value, Amount", "terseLabel": "Debt conversion, fair value" } } }, "auth_ref": [] }, "vsee_DebtConvertibleOriginalDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtConvertibleOriginalDebtAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of debt convertible into shares of common stock.", "label": "Debt Convertible, Original Debt, Amount", "terseLabel": "Aggregate amount of debt convertible", "verboseLabel": "Exchange value" } } }, "auth_ref": [] }, "vsee_DebtDefaultInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtDefaultInterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of interest due to default of debt repayment.", "label": "Debt, Default Interest Expense", "terseLabel": "Default interest expense" } } }, "auth_ref": [] }, "vsee_DebtDefaultPercentageOfMandatoryPenalty": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtDefaultPercentageOfMandatoryPenalty", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of mandatory penalty for debt default.", "label": "Debt, Default, Percentage Of Mandatory Penalty", "terseLabel": "Mandatory default penalty (in percentage)" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Line of Credit and Notes Payable, Net of Discount" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscount" ], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "Line of Credit and Notes Payable, Net of Discount", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r135", "r230", "r396", "r397", "r398", "r399", "r400", "r407", "r408", "r420", "r426", "r427", "r428", "r429", "r430", "r431", "r436", "r443", "r444", "r446", "r628" ] }, "vsee_DebtInstrumentAdditionalInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentAdditionalInterestRate", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of increased interest rate.", "label": "Debt Instrument, Additional Interest Rate", "terseLabel": "Rate for additional interest" } } }, "auth_ref": [] }, "vsee_DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "The aggregate principal value of debt instrument agreed to be purchased by the counterparty.", "label": "Debt Instrument, Aggregate Principal Value Agreed To Be Purchased By Counterparty", "terseLabel": "Aggregate principal value agreed to be purchased by the Bridge Investor" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r19", "r96", "r97", "r160", "r164", "r239", "r421", "r422", "r423", "r424", "r425", "r427", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r943", "r944", "r945", "r946", "r947", "r973", "r1152", "r1200", "r1201", "r1202", "r1273", "r1275" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on the variable rate (in %)", "verboseLabel": "Basis spread on the variable rate (in percentage)", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "terseLabel": "Principal balance of debt", "verboseLabel": "Amount allocated to the principal balance of the note", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r19", "r164", "r447" ] }, "vsee_DebtInstrumentCashPaymentFee": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentCashPaymentFee", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of fee chargeable on payments not made via draws on line of credit.", "label": "Debt Instrument, Cash Payment Fee", "terseLabel": "Cash payment fee percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument, Convertible, Average Price for Stock Price Trigger for Reset of Conversion Price", "terseLabel": "Average price for share price trigger to determine reset of conversion price (in dollars per share)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPriceMinimum": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPriceMinimum", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument, Convertible, Average Price for Stock Price Trigger for Reset of Conversion Price, Minimum", "terseLabel": "Minimum average price for share price trigger to determine reset of conversion price (in dollars per share)" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in dollars per share)", "verboseLabel": "Conversion price of debt", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r136", "r423" ] }, "vsee_DebtInstrumentConvertibleMaximumResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleMaximumResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum share price up to which the conversion price of the convertible debt instrument can be reset.", "label": "Debt Instrument, Convertible, Maximum Reset of Conversion Price", "terseLabel": "Maximum reset of conversion price (in dollars per share)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum conversion price to make amortization payment on convertible debt instruments.", "label": "Debt Instrument, Convertible, Minimum Conversion Price to make Amortization Payment", "terseLabel": "Minimum conversion price to make amortization payment (in dollars per share)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertiblePercentageDiscountToVWPUsedToDetermineConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertiblePercentageDiscountToVWPUsedToDetermineConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage discount to prior trading day VWAP used to determine conversion price in conversion of debt instrument to equity instrument.", "label": "Debt Instrument, Convertible, Percentage Discount To V W A P Used To Determine Conversion Price", "terseLabel": "Percentage discount on VWAP" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleQualifiedFinancingPercentageOfEffectivePricePerShare": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleQualifiedFinancingPercentageOfEffectivePricePerShare", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of effective price per share for conversion by holder of debt instrument in qualified financing.", "label": "Debt Instrument, Convertible, Qualified Financing, Percentage of Effective Price Per Share", "terseLabel": "Percentage of effective price per share for conversion of debt in qualified financing" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleResetConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleResetConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Reset conversion price of the convertible debt instrument as of the reporting date due to triggering of the event.", "label": "Debt Instrument, Convertible, Reset Conversion Price", "terseLabel": "Conversion price of exchange note was reset (in dollars per share)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for reset of conversion price of the convertible debt instrument.", "label": "Debt Instrument, Convertible, Stock Price Trigger for Reset of Conversion Price", "terseLabel": "Share price trigger to determine reset of conversion price (in dollars per share)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleTermAfterIssuanceOfDebt": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleTermAfterIssuanceOfDebt", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period after the issuance date during which the holder becomes eligible to convert the convertible promissory note", "label": "Debt Instrument, Convertible, Term After Issuance of Debt", "terseLabel": "Term for conversion of debt after issuance of debt" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForAmortizationConversionPriceDetermination": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForAmortizationConversionPriceDetermination", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold minimum percentage of average lowest VWAP of common stock considered to determine the amortization conversion price of convertible debt instruments, if common stock is used to make such amortization payments.", "label": "Debt Instrument, Convertible, Threshold Percentage Of Average Lowest Volume Weighted Average Price Considered for Amortization Conversion Price Determination", "terseLabel": "Percentage of average lowest VWAP of common stock considered for determination of Amortization Conversion Price (in percentage)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForResetOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold minimum percentage of average lowest VWAP of common stock considered to determine reset value of conversion price of convertible debt instruments.", "label": "Debt Instrument, Convertible, Threshold Percentage Of Average Lowest Volume Weighted Average Price Considered for Reset of Conversion Price", "terseLabel": "Threshold percentage of average lowest VWAP of DHAC's common stock to determine reset of conversion price (in percentage)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold percentage of lowest VWAP of common stock considered to determine conversion price of convertible debt instruments.", "label": "Debt Instrument, Convertible, Threshold Percentage Of Lowest Volume Weighted Average Price Considered for Determination of Conversion Price", "terseLabel": "Threshold percentage of lowest VWAP of common stock to determine conversion price (in percentage)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysForAmortizationConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysForAmortizationConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days prior to amortization payment to determine amortization conversion price of convertible debt instruments, if common stock is used to make such amortization payments.", "label": "Debt Instrument, Convertible, Threshold Trading Days for Amortization Conversion Price", "terseLabel": "Number of trading days to determine Amortization Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days to determine reset of conversion price.", "label": "Debt Instrument, Convertible, Threshold Trading Days for Reset of Conversion Price", "terseLabel": "Number of trading days to determine reset of conversion price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysOverWhichAverageDailyVolumeWeightedAveragePriceOfCommonStockConsideredForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysOverWhichAverageDailyVolumeWeightedAveragePriceOfCommonStockConsideredForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of trading days over which daily average VWAP of common stock is considered to reset the conversion price of convertible debt instruments.", "label": "Debt Instrument, Convertible, Threshold Trading Days Over Which The Average Daily Volume Weighted Average Price Of Common Stock Considered For Reset Of Conversion Price", "terseLabel": "Threshold trading days over which the average daily VWAP of common stock is considered for reset of conversion price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysOverWhichLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysOverWhichLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of trading days over which lowest VWAP of common stock is considered to determine conversion price of convertible debt instruments.", "label": "Debt Instrument, Convertible, Threshold Trading Days Over Which Lowest Volume Weighted Average Price Considered for Determination of Conversion Price", "terseLabel": "Threshold trading days over which the lowest VWAP of common stock is considered to determine conversion price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentDefaultInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentDefaultInterestRate", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of interest chargeable on making default in payments on promissory note from the default date.", "label": "Debt Instrument, Default Interest Rate", "terseLabel": "Default interest rate", "verboseLabel": "Default interest rate (in percent)" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Principal balance of promissory note", "verboseLabel": "Aggregate principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r421", "r628", "r629", "r944", "r945", "r973" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Aggregate current value", "verboseLabel": "Fair value", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r434", "r619", "r944", "r945", "r1263", "r1264", "r1265", "r1266", "r1268" ] }, "vsee_DebtInstrumentForbearanceAgreementDailyInterestRate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentForbearanceAgreementDailyInterestRate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of daily interest payments agreed to be made after a certain date as a consideration for the forbearance of bank on its collection rights.", "label": "Debt Instrument, Forbearance Agreement, Daily Interest Rate", "terseLabel": "Payments for forbearance, daily interest rate" } } }, "auth_ref": [] }, "vsee_DebtInstrumentForbearanceAgreementPaymentsAgreedToBeMade": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentForbearanceAgreementPaymentsAgreedToBeMade", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payments agreed to be made as a consideration for the forbearance of bank on its collection rights.", "label": "Debt Instrument, Forbearance Agreement, Payments Agreed to be Made", "terseLabel": "Payments for forbearance" } } }, "auth_ref": [] }, "vsee_DebtInstrumentForbearanceAgreementPrejudgmentInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentForbearanceAgreementPrejudgmentInterest", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of prejudgment interest payments agreed to be made as a consideration for the forbearance of bank on its collection rights.", "label": "Debt Instrument, Forbearance Agreement, Prejudgment Interest", "terseLabel": "Payments for forbearance, prejudgment interest" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Interest rate (in %)", "verboseLabel": "Weighted average effective interest rate of notes payable (%)", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r99", "r449", "r628", "r629", "r973" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Annual fixed interest rate (in percentage)", "verboseLabel": "Debt instrument interest rate (in percentage)", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r99", "r422" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Commitments, Contingencies, and Concentration Risk", "verboseLabel": "Line of Credit and Notes Payable, Net of Discount", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r239", "r421", "r422", "r423", "r424", "r425", "r427", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r445", "r943", "r944", "r945", "r946", "r947", "r973", "r1152", "r1273", "r1275" ] }, "us-gaap_DebtInstrumentMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentMeasurementInput", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Measurement Input", "terseLabel": "Measurement input of notes payable", "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "vsee_DebtInstrumentMinimumInterestAmountToBePaidUponIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentMinimumInterestAmountToBePaidUponIssuance", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum interest amount to be paid upon issuance of debt.", "label": "Debt Instrument, Minimum Interest Amount to be Paid Upon issuance", "terseLabel": "Minimum interest to be paid upon issuance of debt" } } }, "auth_ref": [] }, "vsee_DebtInstrumentModificationMinimumActualChangeInCashFlow": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentModificationMinimumActualChangeInCashFlow", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum percentage of change in cash flow achieved by the loan modification.", "label": "Debt Instrument Modification, Minimum Actual Change In Cash Flow", "terseLabel": "Minimum percentage change to cash flow" } } }, "auth_ref": [] }, "vsee_DebtInstrumentModificationMinimumActualChangeInFairValue": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentModificationMinimumActualChangeInFairValue", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum percentage of change in fair value achieved by the loan modification.", "label": "Debt Instrument Modification, Minimum Actual Change In Fair Value", "terseLabel": "Minimum percentage change to fair value" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r19", "r239", "r421", "r422", "r423", "r424", "r425", "r427", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r943", "r944", "r945", "r946", "r947", "r973", "r1152", "r1200", "r1201", "r1202", "r1273", "r1275" ] }, "vsee_DebtInstrumentPercentageOfOriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPercentageOfOriginalIssueDiscount", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of debt original issue discount.", "label": "Debt Instrument Percentage Of Original Issue Discount", "terseLabel": "Original issue discount (in percentage)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrepaymentPenalty": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPercentageOfPrepaymentPenalty", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the prepayment penalty rate of debt instrument.", "label": "Debt Instrument, Percentage of Prepayment Penalty", "terseLabel": "Prepayment penalty rate (in percent)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the prepayment penalty rate of debt instrument in case of default.", "label": "Debt Instrument, Percentage of Prepayment Penalty in case of Default", "terseLabel": "Prepayment penalty rate in case of default (in percent)" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of principal of the debt that is estimated to be recoverable in the event of default.", "label": "Debt Instrument, Percentage Of Principal Estimated Recovered In Event Of Default", "terseLabel": "Percentage of lender recovery on principal outstanding" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPeriodOfGuaranteedInterestPayment": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPeriodOfGuaranteedInterestPayment", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The period during which payment of interest is guaranteed regardless of early payment or redemption of notes.", "label": "Debt Instrument, Period Of Guaranteed Interest Payment", "terseLabel": "Period of guaranteed interest payment" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment", "terseLabel": "Periodic payment", "verboseLabel": "Monthly payments", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r19", "r92" ] }, "vsee_DebtInstrumentPeriodicPaymentNumberOfInstallments": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPeriodicPaymentNumberOfInstallments", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of installments for periodic payment of debt instrument.", "label": "Debt Instrument Periodic Payment, Number Of Installments", "terseLabel": "Number of installments" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment, Principal", "terseLabel": "Periodic principal payment", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r19" ] }, "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid", "terseLabel": "Periodic payment terms, balloon payment to be paid", "verboseLabel": "payment to be paid", "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt." } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPrincipalAmountIssuable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the principal amount of debt issuable.", "label": "Debt Instrument, Principal Amount Issuable", "terseLabel": "Principal amount of debt issuable" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountNotExchangeable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPrincipalAmountNotExchangeable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "The principal amount of debt that is non exchangeable.", "label": "Debt Instrument, Principal Amount Not Exchangeable", "terseLabel": "Principal amount not exchangeable", "verboseLabel": "Principal amount not exchangeable" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountPurchasedOnLaterDate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPrincipalAmountPurchasedOnLaterDate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "The principal amount of debt which is purchased on the later date.", "label": "Debt Instrument, Principal Amount, Purchased On Later Date", "terseLabel": "Notes purchased on the later date" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountPurchasedOnSigningDate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentPrincipalAmountPurchasedOnSigningDate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "The principal amount of debt which is purchased on the date of signing of the agreement.", "label": "Debt Instrument, Principal Amount, Purchased On Signing Date", "terseLabel": "Notes purchased on the date of signing of Bridge Letter Agreement" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRedemptionPeriodAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Axis]", "documentation": "Information by period of debt redemption feature under terms of debt agreement." } } }, "auth_ref": [ "r170" ] }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRedemptionPeriodDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Domain]", "documentation": "Period as defined under terms of the debt agreement for debt redemption features." } } }, "auth_ref": [ "r170" ] }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRedemptionPeriodOneMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Redemption period one", "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r170" ] }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentRedemptionPeriodTwoMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Redemption period two", "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r170" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r19", "r58", "r62", "r91", "r139", "r140", "r239", "r421", "r422", "r423", "r424", "r425", "r427", "r432", "r433", "r434", "r435", "r437", "r438", "r439", "r440", "r441", "r442", "r445", "r943", "r944", "r945", "r946", "r947", "r973", "r1152", "r1273", "r1275" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Term", "terseLabel": "Term of debt", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "vsee_DebtInstrumentTermOfInterestToBePaidUponIssuance": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentTermOfInterestToBePaidUponIssuance", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the term of interest to be paid upon issuance of debt.", "label": "Debt Instrument, Term of Interest to be Paid Upon Issuance", "terseLabel": "Term of interest to be paid upon issuance of debt" } } }, "auth_ref": [] }, "vsee_DebtInstrumentTotalInterestExpenseOverLifeOfLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DebtInstrumentTotalInterestExpenseOverLifeOfLoan", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Total amount, over entire maturity, of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Debt Instrument, Total Interest Expense Over Life Of Loan", "terseLabel": "Total interest over entire loan maturity" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Original issue discount", "verboseLabel": "Unamortized debt discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1212", "r1272", "r1273", "r1275" ] }, "us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentVariableInterestRateTypeExtensibleEnumeration", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]", "terseLabel": "Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]", "documentation": "Indicates type of variable interest rate on debt instrument." } } }, "auth_ref": [ "r739" ] }, "us-gaap_DebtPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Original Issue Discount on Debt", "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt." } } }, "auth_ref": [ "r6" ] }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Related Commitment Fees and Debt Issuance Costs", "terseLabel": "Debt issuance costs expensed", "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses." } } }, "auth_ref": [ "r121" ] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1154", "r1253", "r1254" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "totalLabel": "Total deferred provision (benefit)", "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1245" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Deferred provision (benefit):" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "terseLabel": "Financing cost", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1212", "r1272", "r1273", "r1275" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes", "verboseLabel": "Deferred tax asset and liabilities", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r4", "r190", "r1154" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r103", "r104", "r162", "r547" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r533", "r534", "r742" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1154", "r1253", "r1254" ] }, "vsee_DeferredTaxAssetAccruedInterestRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxAssetAccruedInterestRelatedParty", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from accrued interest pertaining to related party.", "label": "Deferred Tax Asset, Accrued Interest, Related Party", "terseLabel": "Accrued interest, related party" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetInterestCarryforward", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest payable", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward." } } }, "auth_ref": [ "r1251" ] }, "vsee_DeferredTaxAssetsBadDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxAssetsBadDebtExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from bad debt expense.", "label": "Deferred Tax Assets, Bad Debt Expense", "terseLabel": "Bad debt expense" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsDeferredIncome", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Deferred Income", "terseLabel": "Deferred revenue", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income." } } }, "auth_ref": [ "r1251" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r548" ] }, "vsee_DeferredTaxAssetsLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxAssetsLeaseLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.", "label": "Deferred Tax Assets, Lease Liabilities", "terseLabel": "Lease liabilities" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net deferred tax assets", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1249" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r1251" ] }, "vsee_DeferredTaxAssetsPayrollLiabilitiesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxAssetsPayrollLiabilitiesPayable", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from payroll liabilities payable.", "label": "Deferred Tax Assets, Payroll Liabilities Payable", "terseLabel": "Payroll liabilities payable" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Property, Plant and Equipment", "terseLabel": "Fixed assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment." } } }, "auth_ref": [ "r1251" ] }, "vsee_DeferredTaxAssetsStartUpCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxAssetsStartUpCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from start-up costs.", "label": "Deferred Tax Assets, Start Up Costs", "terseLabel": "Start-up costs" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "terseLabel": "Deferred compensation", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs." } } }, "auth_ref": [ "r1251" ] }, "vsee_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from accounts payable and accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r549" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Total deferred tax assets (liabilities)", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r1249" ] }, "vsee_DeferredTaxLiabilitiesAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxLiabilitiesAccountsReceivable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from accounts receivable.", "label": "Deferred Tax Liabilities, Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxLiabilitiesAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from amortization.", "label": "Deferred Tax Liabilities, Amortization", "negatedLabel": "Amortization" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxLiabilitiesDepreciation", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from depreciation.", "label": "Deferred Tax Liabilities, Depreciation", "negatedLabel": "Depreciation" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesPrepaidsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredTaxLiabilitiesPrepaidsAndOtherCurrentAssets", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from prepaids and other current assets.", "label": "Deferred Tax Liabilities, Prepaids And Other Current Assets", "negatedLabel": "Prepaids and other current assets" } } }, "auth_ref": [] }, "vsee_DeferredUnderwritingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DeferredUnderwritingFee", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of deferred underwriting fee payable by the company.", "label": "Deferred Underwriting Fee", "terseLabel": "Deferred underwriting fee" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation", "terseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r49" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r4", "r49" ] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Instruments", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r14", "r83", "r84", "r85", "r86", "r238", "r255" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r152", "r1189", "r1190", "r1191", "r1192", "r1193", "r1195", "r1198", "r1199" ] }, "vsee_DhacPublicShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DhacPublicShareholdersMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to DHAC public shareholders.", "label": "DHAC Public Shareholders [Member]", "terseLabel": "DHAC public shareholders" } } }, "auth_ref": [] }, "vsee_DhacShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DhacShareholdersMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to DHAC shareholders.", "label": "DHAC Shareholders [Member]", "terseLabel": "DHAC stockholders" } } }, "auth_ref": [] }, "vsee_DigitalHealthAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DigitalHealthAcquisitionCorpMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Digital Health Acquisition Corp.", "label": "Digital Health Acquisition Corp [Member]", "terseLabel": "DHAC" } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "DirectorMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Board of directors" } } }, "auth_ref": [ "r1172", "r1327" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r1009", "r1010", "r1033" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r1009", "r1010", "r1033", "r1076" ] }, "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Restatement Recovery Analysis [Flag]", "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)." } } }, "auth_ref": [ "r1009", "r1010", "r1033", "r1076" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationLineItems", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationTable", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1054" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_DomesticCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DomesticCountryMember", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Domestic Tax Jurisdiction [Member]", "terseLabel": "Domestic Country", "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction." } } }, "auth_ref": [ "r536" ] }, "vsee_DominionMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "DominionMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to dominion.", "label": "Dominion [Member]", "terseLabel": "Dominion" } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r1065" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Basic loss per common share (in dollars per share)", "verboseLabel": "Net loss per share - basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r220", "r245", "r246", "r248", "r249", "r250", "r252", "r257", "r259", "r262", "r263", "r264", "r267", "r566", "r576", "r594", "r595", "r736", "r760", "r925" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted loss per common share (in dollars per share)", "verboseLabel": "Net loss per share - diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r220", "r245", "r246", "r248", "r249", "r250", "r252", "r259", "r262", "r263", "r264", "r267", "r566", "r576", "r594", "r595", "r736", "r760", "r925" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r32", "r33", "r266" ] }, "us-gaap_EarningsPerShareReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareReconciliationAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Net Loss Per Common Share" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate, percentage", "totalLabel": "Income tax provision", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r536", "r959" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "verboseLabel": "U.S. statutory rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r233", "r536", "r557", "r959" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r540", "r959", "r1155", "r1246" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent", "terseLabel": "Goodwill impairment", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss." } } }, "auth_ref": [ "r959", "r1155", "r1246", "r1247" ] }, "vsee_EffectiveIncomeTaxRateReconciliationPermanentDifferencesNetPercent": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesNetPercent", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable net permanent differences.", "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Net, Percent", "negatedLabel": "Permanent differences, net" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to return to provision.", "label": "Effective Income Tax Rate Reconciliation, Return To Provision, Percent", "negatedLabel": "Return to provision" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "verboseLabel": "State taxes, net of federal", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r539", "r959", "r1155", "r1246" ] }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "terseLabel": "Fair value of the embedded derivative at issuance", "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability." } } }, "auth_ref": [ "r157", "r1264", "r1265", "r1266" ] }, "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative, Gain (Loss) on Embedded Derivative, Net", "terseLabel": "Change in fair value on embedded derivative", "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period." } } }, "auth_ref": [ "r1258" ] }, "us-gaap_EmbeddedDerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmbeddedDerivativeLiabilityMeasurementInput", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative Liability, Measurement Input", "terseLabel": "Measurement input", "documentation": "Value of input used to measure embedded derivative liability." } } }, "auth_ref": [ "r599", "r600", "r601" ] }, "vsee_EmergingGrowthCompanyPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EmergingGrowthCompanyPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for emerging growth company.", "label": "Emerging Growth Company, Policy [Policy Text Block]", "verboseLabel": "Implications of Being an Emerging Growth Company" } } }, "auth_ref": [] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Employee Benefits and Share-Based Compensation", "terseLabel": "Compensation and related benefits", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation and benefits", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r97" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1243" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock options, issued and outstanding", "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "vsee_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EmployeesMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to employees.", "label": "Employees [Member]", "terseLabel": "Employee" } } }, "auth_ref": [] }, "vsee_EncompassHealthcareBillingLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EncompassHealthcareBillingLlcMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Encompass Healthcare Billing, LLC.", "label": "Encompass Healthcare Billing, LLC [Member]", "terseLabel": "Encompass Healthcare Billing, LLC" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1007" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "All Entities [Member]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1007" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r1118" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1007" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1116" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1007" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1007" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1007" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1007" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r1117" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r1059" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r1112" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r1112" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r1112" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r13", "r195", "r217", "r218", "r219", "r240", "r241", "r242", "r244", "r250", "r253", "r255", "r269", "r347", "r350", "r394", "r469", "r555", "r556", "r563", "r564", "r565", "r567", "r575", "r576", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r621", "r622", "r623", "r624", "r625", "r626", "r631", "r633", "r651", "r758", "r782", "r783", "r784", "r810", "r878" ] }, "vsee_EquityFinancingMaximumRemainingShareCapacityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EquityFinancingMaximumRemainingShareCapacityAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Maximum amount of share capacity available for issuance under the equity financing.", "label": "Equity Financing, Maximum Remaining Share Capacity, Amount", "terseLabel": "Maximum remaining availability under the ELOC" } } }, "auth_ref": [] }, "vsee_EquityIncentivePlan2024Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EquityIncentivePlan2024Member", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to 2024 Equity Incentive Plan.", "label": "Equity Incentive Plan 2024 [Member]", "terseLabel": "Incentive Plan" } } }, "auth_ref": [] }, "vsee_EquityLineOfCreditCommitmentFeeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EquityLineOfCreditCommitmentFeeNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to equity line of credit commitment fee note.", "label": "Equity Line Of Credit, Commitment Fee Note [Member]", "terseLabel": "ELOC Commitment Fee Note" } } }, "auth_ref": [] }, "vsee_EquityLineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EquityLineOfCreditMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to equity line of credit.", "label": "Equity Line Of Credit [Member]", "terseLabel": "Equity Line of Credit", "verboseLabel": "Equity line of credit" } } }, "auth_ref": [] }, "vsee_EquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EquityPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to equity purchase agreement.", "label": "Equity Purchase Agreement [Member]", "terseLabel": "Equity Purchase Agreement" } } }, "auth_ref": [] }, "vsee_EquityPurchaseCommitmentNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EquityPurchaseCommitmentNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Equity Purchase Commitment Note.", "label": "Equity Purchase Commitment Note [Member]", "terseLabel": "Equity Purchase Commitment Note" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r1069" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r1026", "r1037", "r1047", "r1080" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r1023", "r1034", "r1044", "r1077" ] }, "vsee_ErrorCorrectionFailureToIdentifyAndAccrueForSalesAndUseTaxesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionFailureToIdentifyAndAccrueForSalesAndUseTaxesMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to type of error related to failure of recording accrual for sales and use taxes.", "label": "Error Correction, Failure To Identify And Accrue For Sales And Use Taxes [Member]", "terseLabel": "Failure to identify and accrue for sales and use taxes" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectClassificationOfAcquisitionOfRemainingNonControllingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectClassificationOfAcquisitionOfRemainingNonControllingInterestsMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect classification of the acquisition of the remaining non-controlling interests.", "label": "Error Correction, Incorrect Classification Of Acquisition Of Remaining Non-Controlling Interests [Member]", "terseLabel": "Incorrect classification of acquisition of remaining non-controlling interest" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectCutoffOfRevenueTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectCutoffOfRevenueTransactionMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect cutoff of a revenue transaction with a customer.", "label": "Error Correction, Incorrect Cutoff Of Revenue Transaction [Member]", "terseLabel": "Incorrect Cutoff of revenue transaction" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionAndMeasurementOfAccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionAndMeasurementOfAccountsReceivableMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to incorrect recognition and measurement of accounts receivable.", "label": "Error Correction, Incorrect Recognition And Measurement Of Accounts Receivable [Member]", "terseLabel": "Incorrect recognition and measurement of accounts receivable balances" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionOfAccruedExpensesPertainingToCashAndStockCompensationMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionOfAccruedExpensesPertainingToCashAndStockCompensationMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect recognition of accrued expenses pertaining to cash and stock compensation.", "label": "Error Correction, Incorrect Recognition Of Accrued Expenses Pertaining To Cash And Stock Compensation [Member]", "terseLabel": "Incorrect recognition of accrued expenses pertaining to cash and stock compensation" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionOfAccruedExpensesPertainingToTransactionExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionOfAccruedExpensesPertainingToTransactionExpensesMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect recognition of accrued expenses pertaining to transaction expenses.", "label": "Error Correction, Incorrect Recognition Of Accrued Expenses Pertaining To Transaction Expenses [Member]", "terseLabel": "Incorrect recognition of accrued expenses pertaining to transaction expenses" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionOfAccruedInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionOfAccruedInterestMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect recognition of accrued interest.", "label": "Error Correction, Incorrect Recognition Of Accrued Interest [Member]", "terseLabel": "Incorrect recognition of accrued interest" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionOfCertainIncomeTaxRelatedBalanceMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionOfCertainIncomeTaxRelatedBalanceMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect recognition of recognition of certain income tax-related balances as of the Business Combination date.", "label": "Error Correction, Incorrect Recognition Of Certain Income Tax Related Balance [Member]", "terseLabel": "Incorrect recognition of certain income tax-related balances as of the Business Combination date" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionOfCommitmentFeeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionOfCommitmentFeeMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect recognition of commitment fee.", "label": "Error Correction, Incorrect Recognition Of Commitment Fee [Member]", "terseLabel": "Incorrect recognition of commitment fee" } } }, "auth_ref": [] }, "vsee_ErrorCorrectionIncorrectRecognitionOfGrantDateFairValueOfOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ErrorCorrectionIncorrectRecognitionOfGrantDateFairValueOfOptionsMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to incorrect recognition of grant date fair value of options.", "label": "Error Correction, Incorrect Recognition Of Grant Date Fair Value Of Options [Member]", "terseLabel": "Incorrect recognition of grant date fair value" } } }, "auth_ref": [] }, "us-gaap_ErrorCorrectionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ErrorCorrectionTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatements" ], "lang": { "en-us": { "role": { "label": "Error Correction [Text Block]", "terseLabel": "Restatement of Previously Issued Financial Statements", "documentation": "The entire disclosure for reporting error correction." } } }, "auth_ref": [ "r251" ] }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Error Correction, Type [Axis]", "documentation": "Information by type of error correction." } } }, "auth_ref": [ "r245", "r246", "r247", "r252", "r253", "r254", "r255" ] }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "terseLabel": "Restatement of Previously Issued Financial Statements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r245", "r246", "r247", "r252", "r253", "r254", "r255", "r267" ] }, "vsee_EstimatedValueOfSharesAndOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "EstimatedValueOfSharesAndOptionsGranted", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "documentation": "The estimated value of shares and options granted.", "label": "Estimated Value of Shares and Options Granted", "terseLabel": "Shares and options granted" } } }, "auth_ref": [] }, "vsee_ExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Exchange Agreement.", "label": "Exchange Agreement [Member]", "terseLabel": "Exchange Agreement" } } }, "auth_ref": [] }, "vsee_ExchangeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExchangeNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Exchange Note.", "label": "Exchange Note [Member]", "terseLabel": "Exchange Note" } } }, "auth_ref": [] }, "vsee_ExchangeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExchangeNotesMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to exchange note.", "label": "Exchange Notes [Member]", "terseLabel": "Exchange Note, at fair value", "verboseLabel": "Exchange Note" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r1075" ] }, "vsee_ExtensionNoteBifurcatedDerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExtensionNoteBifurcatedDerivativeMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to extension note - bifurcated derivative.", "label": "Extension Note Bifurcated Derivative [Member]", "terseLabel": "Extension Note - Bifurcated Derivative" } } }, "auth_ref": [] }, "vsee_ExtensionNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExtensionNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Extension Note.", "label": "Extension Note [Member]", "terseLabel": "Extension Note" } } }, "auth_ref": [] }, "vsee_ExtensionNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExtensionNotesMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to extension notes Member.", "label": "Extension Notes [Member]", "terseLabel": "Extension Note" } } }, "auth_ref": [] }, "vsee_ExtensionWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ExtensionWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Extension Warrants.", "label": "Extension Warrants [Member]", "terseLabel": "Extension Warrants" } } }, "auth_ref": [] }, "vsee_FactoringPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FactoringPayableAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Factoring Payable" } } }, "auth_ref": [] }, "vsee_FactoringPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FactoringPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of factoring payable, classified as current.", "label": "Factoring Payable Current", "terseLabel": "Factoring payable" } } }, "auth_ref": [] }, "vsee_FactoringPayableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FactoringPayableLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Factoring Payable [Line Items]", "terseLabel": "Factoring Payable" } } }, "auth_ref": [] }, "vsee_FactoringPayableTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FactoringPayableTable", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information pertaining to factoring payables.", "label": "Factoring Payable [Table]" } } }, "auth_ref": [] }, "vsee_FactoringPayableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FactoringPayableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayable" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of Factoring Payable.", "label": "Factoring Payable[Text Block]", "terseLabel": "Factoring Payable" } } }, "auth_ref": [] }, "vsee_FairValueAdjustmentOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FairValueAdjustmentOfFinancialInstruments", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 5.0 }, "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of financial instruments.", "label": "Fair Value Adjustment of Financial Instruments", "negatedLabel": "Change in fair value of financial instruments", "terseLabel": "Change in fair value of financial instruments" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r597", "r598", "r611", "r962" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r597", "r598", "r611", "r962" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r599", "r600", "r601", "r966" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r599", "r600", "r601", "r966" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of key inputs", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r599", "r600", "r966" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r434", "r484", "r485", "r486", "r487", "r488", "r489", "r596", "r598", "r599", "r600", "r601", "r610", "r611", "r613", "r667", "r668", "r669", "r944", "r945", "r952", "r953", "r954", "r962", "r966" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r597", "r598", "r599", "r601", "r962", "r1265", "r1270" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r606", "r608", "r609", "r610", "r613", "r614", "r615", "r616", "r617", "r734", "r962", "r967" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r434", "r484", "r489", "r598", "r611", "r667", "r952", "r953", "r954", "r962" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r434", "r484", "r485", "r486", "r487", "r488", "r489", "r598", "r599", "r600", "r601", "r611", "r669", "r944", "r945", "r952", "r953", "r954", "r962", "r966" ] }, "vsee_FairValueLiabilitiesLevel1ToLevel2TransfersAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FairValueLiabilitiesLevel1ToLevel2TransfersAmount1", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsTransfersDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount 1", "terseLabel": "Transfer liabilities, level 1 to level 2" } } }, "auth_ref": [] }, "vsee_FairValueLiabilitiesLevel2ToLevel1TransfersAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FairValueLiabilitiesLevel2ToLevel1TransfersAmount1", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsTransfersDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount 1", "terseLabel": "Transfer liabilities, level 2 to level 1" } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of fair value information on recurring basis", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r1262", "r1263" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r602", "r603", "r604", "r605", "r606", "r607" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input." } } }, "auth_ref": [ "r602", "r603", "r604", "r605", "r606", "r607", "r612" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of changes in the fair value of financial liabilities", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r602", "r607", "r612" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r597", "r598", "r599", "r601", "r962", "r1265", "r1270" ] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of conversion into equity of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Conversion Into Equity", "negatedLabel": "Shares issued upon conversions of portion of notes" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossFromExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossFromExtinguishment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized from extinguishment of debt measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) From Extinguishment", "terseLabel": "(Gain) Loss due to extinguishment of debt" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "(Gain) Loss on change in fair value", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r603", "r612" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "verboseLabel": "Initial fair value at issuance", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r605", "r612" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales", "negatedLabel": "Repayment of Notes", "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r605", "r612" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedLabel": "Settlement of Extension Note", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r605", "r612" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsTransfersDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfer liabilities, level 3", "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r1267", "r1269" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value as of end of the year", "periodStartLabel": "Fair value as of beginning of the year", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r602", "r612" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r434", "r484", "r485", "r486", "r487", "r488", "r489", "r596", "r598", "r599", "r600", "r601", "r610", "r611", "r613", "r667", "r668", "r669", "r944", "r945", "r952", "r953", "r954", "r962", "r966" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r962", "r1262", "r1263", "r1264", "r1265", "r1266", "r1270" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r8" ] }, "vsee_FairValueOfSharesOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FairValueOfSharesOfCommonStock", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Amounts of fair values of common stock", "label": "Fair Value Of The Shares Of Common Stock", "terseLabel": "Fair value of shares issued to vendor for service" } } }, "auth_ref": [] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "(Gain) Loss on change in fair value, Income Statement Location", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r603", "r612" ] }, "vsee_FinanceLeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FinanceLeaseCostTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's finance lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease.", "label": "Finance Lease Cost [Table Text Block]", "terseLabel": "Schedule of expenses incurred with respect to finance leases" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Expense", "terseLabel": "Finance lease interest", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r637", "r642", "r975" ] }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]", "terseLabel": "Finance Lease - Future minimum rent payments" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails", "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability", "terseLabel": "Present value of payments", "totalLabel": "Equipment lease", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r635", "r647" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails": { "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Current", "negatedLabel": "Less: Current portion", "verboseLabel": "Financing lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r635" ] }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes current finance lease liability." } } }, "auth_ref": [ "r636" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]", "terseLabel": "Schedule of future minimum payments under finance lease", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1279" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid", "totalLabel": "Total future minimum lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r647" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "Year ending December 31, 2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r647" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less Imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r647" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Principal Payments", "terseLabel": "Finance lease payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r638", "r644" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "totalLabel": "Leased equipment, net", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r634" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "negatedLabel": "Less: Accumulated amortization", "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease." } } }, "auth_ref": [ "r1123", "r1129" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails", "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Finance lease asset amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r637", "r642", "r975" ] }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Equipment lease", "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r1122" ] }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasedEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset." } } }, "auth_ref": [ "r636" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseWeightedAverageRemainingLeaseTermAndDiscountRateDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r646", "r975" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseWeightedAverageRemainingLeaseTermAndDiscountRateDetails" ], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r645", "r975" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentAxis", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r352", "r353", "r358", "r359", "r360", "r361", "r362", "r363", "r445", "r465", "r590", "r618", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r759", "r940", "r962", "r965", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r977", "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1177", "r1178", "r1179", "r1180", "r1261", "r1264", "r1265", "r1266", "r1268", "r1270" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Fair Value", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [ "r1262", "r1263", "r1268" ] }, "vsee_FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "http://vseehealth.com/role/DisclosureLeasesFinanceLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of financing lease liabilities that are included in accounts payable and accrued liabilities at balance sheet date.", "label": "Financing Lease Liabilities Included In Accounts Payable And Accrued Liabilities", "terseLabel": "Financing lease liabilities included in accounts payable and accrued liabilities", "verboseLabel": "Accrued financing lease" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Estimated useful lives, intangible assets", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r205", "r364", "r385", "r942" ] }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "documentation": "Disclosure of information about finite-lived intangible asset acquired in business combination." } } }, "auth_ref": [ "r47" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Year ending December 31, 2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r387", "r916", "r942" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Year ending December 31, 2029", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r387", "r916", "r942" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Year ending December 31, 2028", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r387", "r916", "r942" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Year ending December 31, 2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r387", "r916", "r942" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Year ending December 31, 2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r387", "r916", "r942" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r378", "r380", "r381", "r382", "r384", "r385", "r389", "r390", "r702", "r703", "r916" ] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r378", "r380", "r381", "r382", "r384", "r385", "r389", "r390", "r916" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r702", "r1195" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets Acquired", "verboseLabel": "Additions", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r380" ] }, "vsee_FiveCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FiveCustomersMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to the five customers.", "label": "Five Customers [Member]", "terseLabel": "Five customers" } } }, "auth_ref": [] }, "vsee_FixedAssetRecognitionThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FixedAssetRecognitionThreshold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "The monetary threshold for which fixed assets are required to be recorded.", "label": "Fixed Asset Recognition Threshold", "terseLabel": "Fixed asset recognition threshold" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1084" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1084" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1084" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1084" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1084" ] }, "vsee_FoundersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FoundersMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to founders.", "label": "Founders [Member]", "verboseLabel": "DHAC founders" } } }, "auth_ref": [] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r1064" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement1Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement1Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 1.", "label": "Future Receipts Sale Agreement 1 [Member]", "terseLabel": "Future Receipts Sale Agreement 1" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement2Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement2Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 2.", "label": "Future Receipts Sale Agreement 2 [Member]", "terseLabel": "Future Receipts Sale Agreement 2" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement3Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement3Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 3.", "label": "Future Receipts Sale Agreement 3 [Member]", "terseLabel": "Future Receipts Sale Agreement 3" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement4Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement4Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 4.", "label": "Future Receipts Sale Agreement 4 [Member]", "terseLabel": "Future Receipts Sale Agreement 4" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement5Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement5Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 5.", "label": "Future Receipts Sale Agreement 5 [Member]", "terseLabel": "Future Receipts Sale Agreement 5" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement6Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement6Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 6.", "label": "Future Receipts Sale Agreement 6 [Member]", "terseLabel": "Future Receipts Sale Agreement 6" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement7Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreement7Member", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to Future Receipts Sale Agreement 7.", "label": "Future Receipts Sale Agreement 7 [Member]", "terseLabel": "Future Receipts Sale Agreement 7" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserDaily": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserDaily", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount to be collected by purchaser daily under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Amount To Be Collected By Purchaser Daily", "terseLabel": "Amount to be collected by purchaser daily" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserWeekly": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserWeekly", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount to be collected by purchaser weekly under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Amount To Be Collected By Purchaser Weekly", "terseLabel": "Amount to be collected by purchaser weekly" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementAxis", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information pertaining to Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement [Axis]" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementBalloonCollectionByPurchaser": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementBalloonCollectionByPurchaser", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount to be collected by purchaser as a final payment under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Balloon Collection By Purchaser", "terseLabel": "Balloon collection" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementDomain", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information pertaining to Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement [Domain]" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementFutureReceiptsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementFutureReceiptsSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of Future receipts sold under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Future Receipts Sold", "terseLabel": "Future receipts sold" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementInterestRate", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the interest rate associated with the transactions under Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Interest rate", "terseLabel": "Interest rate" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementNetSalePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementNetSalePrice", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of Net sales under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Net Sale Price", "terseLabel": "Net purchase price" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly", "presentation": [ "http://vseehealth.com/role/DisclosureFactoringPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period over which the amount is to be collected by purchaser weekly under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement, Period Over Which Amount Is To Be Collected By Purchaser Weekly", "terseLabel": "Period over which amount is to be collected by purchaser weekly" } } }, "auth_ref": [] }, "vsee_GainLossOnDebtConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "GainLossOnDebtConversion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of gain loss recorded during the period on conversion of debt.", "label": "Gain (Loss) on Debt Conversion", "terseLabel": "Gain (loss) on debt conversion" } } }, "auth_ref": [] }, "vsee_GainLossOnIssuanceOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "GainLossOnIssuanceOfFinancialInstruments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 }, "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of financial instruments at issuance recognized in the income statement.", "label": "Gain (Loss) On Issuance Of Financial Instruments", "negatedLabel": "Loss on issuance of financial instruments", "terseLabel": "Loss on issuance of financial instruments" } } }, "auth_ref": [] }, "vsee_GainOnForgivenessOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "GainOnForgivenessOfDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of gain on decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Gain On Forgiveness Of Debt", "negatedLabel": "Gain on forgiveness of debt", "terseLabel": "Gain on forgiveness of debt" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 7.0 }, "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on extinguishment of debt", "terseLabel": "Gain (Loss) on extinguishment of debt", "verboseLabel": "Loss on extinguishment of debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r4", "r51", "r52" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative expenses", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r119", "r858" ] }, "vsee_GeneralOverheadExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "GeneralOverheadExpenses", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of general expenses for a corporate as a whole incurred during the reporting period.", "label": "General Overhead Expenses", "negatedLabel": "Unallocated corporate overhead expenses" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r204", "r366", "r735", "r934", "r941", "r964", "r976", "r1186", "r1187" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r365", "r377", "r941" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Accumulated goodwill impairment", "documentation": "Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r369", "r376", "r941" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment charges", "verboseLabel": "Goodwill impairment", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r4", "r367", "r373", "r377", "r941", "r964" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Gross Profit", "terseLabel": "Gross margin", "totalLabel": "Gross margin", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r113", "r117", "r173", "r232", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r620", "r927", "r933", "r1164", "r1166", "r1168", "r1169", "r1170", "r1207" ] }, "us-gaap_HealthCarePatientServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "HealthCarePatientServiceMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Health Care, Patient Service [Member]", "terseLabel": "Patient fees", "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility." } } }, "auth_ref": [ "r1216" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r1009", "r1010", "r1033" ] }, "vsee_IdocNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IdocNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to iDoc Note.", "label": "IDoc Note [Member]", "terseLabel": "iDoc Note" } } }, "auth_ref": [] }, "vsee_IdocStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IdocStockholdersMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to iDoc stockholders.", "label": "IDoc Stockholders [Member]", "terseLabel": "iDoc stockholders" } } }, "auth_ref": [] }, "vsee_IdocVirtualTelehealthSolutionsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IdocVirtualTelehealthSolutionsIncMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationTables", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to iDoc Virtual Telehealth Solutions, INC.", "label": "IDoc Virtual Telehealth Solutions, Inc [Member]", "terseLabel": "iDoc", "verboseLabel": "IDoc Virtual Telehealth Solutions, Inc" } } }, "auth_ref": [] }, "vsee_IfStockPriceDropsBelow1.25DollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IfStockPriceDropsBelow1.25DollarsMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents scenario information pertaining to stock price drops below $1.25.", "label": "If Stock Price Drops Below1.25 Dollars [Member]", "terseLabel": "Stock Price Drops Below 1.25 Dollars" } } }, "auth_ref": [] }, "vsee_IfStockPriceDropsBelow2DollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IfStockPriceDropsBelow2DollarsMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents scenario information pertaining to stock price drops below $2.", "label": "If stock Price Drops Below 2 Dollars [Member]", "terseLabel": "Stock Price Drops Below 2 Dollars" } } }, "auth_ref": [] }, "vsee_ImoAisikuMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ImoAisikuMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Co-CEO Imo Aisiku.", "label": "Imo Aisiku [Member]", "terseLabel": "Imo Aisiku" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets other than goodwill", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r4", "r379", "r391" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Impairment, Long-Lived Asset, Held-for-Use", "terseLabel": "Impairment of long-lived", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r4", "r48", "r134", "r963" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-Lived and Intangible Assets Other than Goodwill", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "negatedLabel": "Loss before benefit from (provision for) income taxes", "terseLabel": "Loss before taxes", "totalLabel": "Loss before benefit from (provision for) income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r114", "r168", "r173", "r737", "r754", "r927", "r933", "r1164", "r1166", "r1168", "r1169", "r1170" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails" ], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS", "terseLabel": "Consolidated Statement of Operations" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Axis]", "documentation": "Information by income tax jurisdiction." } } }, "auth_ref": [ "r227", "r536", "r537", "r544", "r552", "r959", "r1250" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Domain]", "documentation": "Income tax jurisdiction." } } }, "auth_ref": [ "r227", "r536", "r537", "r544", "r552", "r959", "r1250" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r233", "r530", "r536", "r541", "r542", "r543", "r545", "r551", "r558", "r560", "r561", "r562", "r804", "r959" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 1.0 }, "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "negatedLabel": "Benefit from (provision for) income taxes", "negatedTerseLabel": "Income tax (expense) benefit", "totalLabel": "Income tax provision (benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r179", "r191", "r254", "r255", "r268", "r284", "r305", "r535", "r536", "r559", "r761", "r959" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r216", "r531", "r532", "r545", "r546", "r550", "r554", "r798" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income tax payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r3" ] }, "vsee_IncreaseDecreaseInBenefitFromIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IncreaseDecreaseInBenefitFromIncomeTax", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in benefit from income tax.", "label": "Increase (Decrease) In Benefit From Income Tax", "negatedLabel": "Decrease in benefit from income tax" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r697", "r1150" ] }, "us-gaap_IncreaseDecreaseInDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueFromRelatedParties", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Due from Related Parties", "negatedLabel": "Due from related party", "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Due to Related Parties", "terseLabel": "Due to related party", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "vsee_IncreaseDecreaseInFederalAndStateIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IncreaseDecreaseInFederalAndStateIncomeTaxesPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) in federal and state income taxes payable.", "label": "Increase (Decrease) In Federal And State Income Taxes Payable", "terseLabel": "Increase (decrease) in federal and state income taxes payable" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Lease Liability", "verboseLabel": "Operating lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r1130", "r1150" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaids and other current assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r3" ] }, "vsee_IncreaseDecreaseInPrepaidIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "IncreaseDecreaseInPrepaidIncomeTaxes", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid income taxes.", "label": "Increase (Decrease) In Prepaid Income Taxes", "negatedLabel": "Decrease in prepaid income taxes" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r378", "r383", "r388", "r942" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r378", "r383", "r388", "r942" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1075", "r1084", "r1088", "r1096" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r1094" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r1011", "r1100" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r1011", "r1100" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r1011", "r1100" ] }, "vsee_InstitutionalFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "InstitutionalFeesMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents fess relating to institutional activities.", "label": "Institutional Fees [Member]", "terseLabel": "Institutional fees" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Intangible Assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r698", "r699", "r700", "r702", "r924", "r1188" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r378", "r1195", "r1197" ] }, "vsee_InterestAccruedPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "InterestAccruedPerMonth", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of interest accrued per month.", "label": "Interest Accrued Per Month", "terseLabel": "Interest accrued per month" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "terseLabel": "Total interest expense", "verboseLabel": "Interest expense paid and recorded", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r121", "r440", "r450", "r946", "r947" ] }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseDebtExcludingAmortization", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Interest expense", "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs." } } }, "auth_ref": [ "r121", "r441", "r946", "r947" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Nonoperating", "negatedLabel": "Interest expense", "terseLabel": "Interest expense", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r280", "r1148" ] }, "us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "label": "Interest Income, Financing Receivable, before Allowance for Credit Loss", "terseLabel": "Interest income", "documentation": "Amount of interest income from financing receivable before allowance for credit loss." } } }, "auth_ref": [ "r193", "r194" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest expense", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r222", "r225", "r226" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Interest Payable, Current", "terseLabel": "Accrued interest payable", "verboseLabel": "Accrued interest", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r97" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Interest Payable", "terseLabel": "Accrued interest", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r163", "r1293" ] }, "us-gaap_InternalUseSoftwarePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InternalUseSoftwarePolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Internal Use Software, Policy [Policy Text Block]", "terseLabel": "Capitalized Internal-Use Software Costs", "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally." } } }, "auth_ref": [ "r393" ] }, "us-gaap_InvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestorMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "label": "Investor [Member]", "terseLabel": "Accredited Investor", "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value." } } }, "auth_ref": [ "r1282", "r1283" ] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Shares issued as part of stock grants to vendors", "verboseLabel": "Shares issued as part of stock grants to vendors", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r4" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of expenses incurred for operating leases", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1278" ] }, "vsee_LeaseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LeaseDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeases" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information about leases.", "label": "Lease Disclosure [Text Block]", "terseLabel": "Leases" } } }, "auth_ref": [] }, "vsee_LeasedEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LeasedEquipmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property leased, used to produce goods and services.", "label": "Leased Equipment [Member]", "terseLabel": "Leased equipment" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r133", "r648" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "vsee_LendersUnderARLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LendersUnderARLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to lenders under A&R Loan Conversion SPAs.", "label": "Lenders Under A&R Loan Conversion SPAs [Member]", "terseLabel": "Lenders under A&R Loan Conversion SPAs" } } }, "auth_ref": [] }, "vsee_LendersUnderLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LendersUnderLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to lenders under Loan Conversion SPAs.", "label": "Lenders Under Loan Conversion SPAs [Member]", "terseLabel": "Lenders under Loan Conversion SPAs" } } }, "auth_ref": [] }, "us-gaap_LesseeFinanceLeaseDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeFinanceLeaseDiscountRate", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Finance Lease, Discount Rate", "terseLabel": "Incremental borrowing rate used for finance leases (in %)", "documentation": "Discount rate used by lessee to determine present value of finance lease payments." } } }, "auth_ref": [ "r1277" ] }, "vsee_LesseeFinanceLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeFinanceLeaseLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information relating to components of the lessee's finance lease liabilities.", "label": "Lessee, Finance Lease, Liabilities [Table Text Block]", "terseLabel": "Schedule of finance lease liabilities" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseMonthlyPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeFinanceLeaseMonthlyPayments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of monthly combined lease payments made by the lessee relating to finance leases.", "label": "Lessee, Finance Lease, Monthly Payments", "terseLabel": "Finance lease monthly payments" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseNumberOfLeases": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeFinanceLeaseNumberOfLeases", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesFinanceLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "The total number of finance lease contracts entered into by the lessee during the period.", "label": "Lessee, Finance Lease, Number Of Leases", "terseLabel": "Number of finance leases" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information relating to components of the lessee's finance lease right-of-use assets.", "label": "Lessee, Finance Lease, Right-of-Use Assets [Table Text Block]", "terseLabel": "Schedule of finance leased equipment" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseSupplementalInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeFinanceLeaseSupplementalInformationTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the information pertaining to other supplemental information relating to the lessee's finance leases.", "label": "Lessee, Finance Lease, Supplemental Information [Table Text Block]", "terseLabel": "Schedule of weighted average remaining lease term and discount rate on finance leases" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Leases", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r641", "r649" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r641", "r649" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r640" ] }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseDiscountRate", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Discount Rate", "terseLabel": "Incremental borrowing rate used for operating leases (in %)", "documentation": "Discount rate used by lessee to determine present value of operating lease payments." } } }, "auth_ref": [ "r974" ] }, "vsee_LesseeOperatingLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeOperatingLeaseLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information relating to components of the lessee's operating lease liabilities.", "label": "Lessee, Operating Lease, Liabilities [Table Text Block]", "terseLabel": "Schedule of operating lease liabilities" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "terseLabel": "Schedule of future minimum rent payments under the operating lease", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1279" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total future minimum lease payments", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r647" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "Year ending December 31, 2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r647" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "Year ending December 31, 2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r647" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "Year ending December 31, 2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r647" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "Year ending December 31, 2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r647" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r647" ] }, "vsee_LesseeOperatingLeaseRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information relating to components of the lessee's operating lease right-of-use assets.", "label": "Lessee, Operating Lease, Right-of-Use Assets [Table Text Block]", "terseLabel": "Schedule of operating lease right-of-use assets" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "terseLabel": "Total liabilities", "totalLabel": "Total liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r19", "r96", "r97", "r98", "r100", "r101", "r102", "r105", "r232", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r579", "r582", "r583", "r620", "r833", "r926", "r1005", "r1207", "r1285", "r1286" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "terseLabel": "Total liabilities and stockholders' equity (deficit)", "totalLabel": "Total liabilities and stockholders' equity (deficit)", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r112", "r167", "r749", "r976", "r1153", "r1181", "r1271" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAssumed1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAssumed1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Liabilities Assumed", "terseLabel": "Net liabilities acquired in reverse merger", "documentation": "The fair value of liabilities assumed in noncash investing or financing activities." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "terseLabel": "Total current liabilities", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r98", "r200", "r232", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r579", "r582", "r583", "r620", "r976", "r1207", "r1285", "r1286" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "auth_ref": [] }, "vsee_LineOfCreditIssuedNovember292021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LineOfCreditIssuedNovember292021Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Line of credit issued November 29, 2021", "label": "Line Of Credit Issued November 29, 2021 [Member]", "terseLabel": "Line of credit issued November 29, 2021 (Face Value: $500,000)" } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Line of Credit, Current", "terseLabel": "Line of credit", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r96", "r160" ] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LoansPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Loans Payable, Current", "terseLabel": "Loan payable, related party, net of discount", "verboseLabel": "Loan payable, related party", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r97" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "totalLabel": "Total notes payable", "verboseLabel": "Outstanding balance, promissory note", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r19", "r164", "r433", "r448", "r944", "r945", "r973", "r1294" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Current Maturities", "negatedLabel": "Less: Current portion", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r207" ] }, "vsee_LongTermDebtFairValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LongTermDebtFairValueAdjustments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of increase (decrease) in long term debt from fair value adjustments.", "label": "Long Term Debt, Fair Value Adjustments", "negatedLabel": "Less: Fair value adjustment for debt" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r239", "r1213" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year One", "terseLabel": "Year ending December 31, 2025", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r239", "r438" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "Year ending December 31, 2029", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r239", "r438" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Four", "terseLabel": "Year ending December 31, 2028", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r239", "r438" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Three", "terseLabel": "Year ending December 31, 2027", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r239", "r438" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountPrincipalPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Maturity, Year Two", "terseLabel": "Year ending December 31, 2026", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r239", "r438" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Total notes payable, net of current portion", "verboseLabel": "Notes payable, less current portion, net of discount", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r208" ] }, "us-gaap_LongTermPurchaseCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment, Amount", "terseLabel": "Total purchase commitment", "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Category of Item Purchased [Axis]", "documentation": "Information by category of items purchased under a long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]", "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment [Line Items]", "terseLabel": "Commitments, Contingencies, and Concentration Risk", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentNumberOfRobotsForWhichLifetimeUsePaymentToBeMade": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LongTermPurchaseCommitmentNumberOfRobotsForWhichLifetimeUsePaymentToBeMade", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The total number of robots for which lifetime use payment is required as per the agreement with the vendor.", "label": "Long-Term Purchase Commitment, Number of Robots For Which Lifetime Use Payment To be Made", "terseLabel": "Number of robots for which lifetime use payments is to be made" } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentNumberOfRobotsToBePurchased": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LongTermPurchaseCommitmentNumberOfRobotsToBePurchased", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The total number of robots to be purchased as per the agreement with the vendor.", "label": "Long-Term Purchase Commitment, Number of Robots To Be Purchased", "terseLabel": "Number of robots purchased" } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentTable", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment [Table]", "documentation": "Disclosure of information about long-term purchase arrangement. Includes, but is not limited to, term of arrangement with supplier, minimum quantity required, milestone, period covered by arrangement, and committed amount. Excludes short-term purchase arrangement and unconditional purchase obligation." } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentUnpaidAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LongTermPurchaseCommitmentUnpaidAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "The unpaid amount of the total amount that the the entity agreed to spend under the long-term purchase commitment.", "label": "Long-Term Purchase Commitment, Unpaid Amount", "terseLabel": "Unpaid commitment amount" } } }, "auth_ref": [] }, "vsee_LossContingencyAndReservePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LossContingencyAndReservePolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for estimating the loss if an asset has been impaired or liability had been incurred as of the balance sheet date.", "label": "Loss Contingency and Reserve, Policy [Policy Text Block]", "terseLabel": "Loss Contingencies and Litigation" } } }, "auth_ref": [] }, "vsee_LossOnConversionOfAccountsPayableToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "LossOnConversionOfAccountsPayableToEquity", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of loss recognized on the conversion of accounts payable to equity.", "label": "Loss On Conversion Of Accounts Payable To Equity", "terseLabel": "Loss on extinguishment of accounts payable" } } }, "auth_ref": [] }, "vsee_M2bMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "M2bMember", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to M2B.", "label": "M2B [Member]", "terseLabel": "M2B" } } }, "auth_ref": [] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2024", "localname": "MA", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "MASSACHUSETTS", "terseLabel": "Massachusetts" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r313", "r951", "r987", "r992", "r1215", "r1297", "r1298", "r1299", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]", "terseLabel": "Reconciling items", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r300", "r303", "r306", "r933", "r934" ] }, "vsee_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity of Related Party Promissory Note", "terseLabel": "Maximum borrowing capacity of related party promissory note" } } }, "auth_ref": [] }, "vsee_MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum calendar year days for suspension for use of resale registration statement.", "label": "Maximum Calendar Year Days For Suspension For Use Of Resale Registration Statement", "terseLabel": "Maximum calendar year days for suspension for use of resale registration statement" } } }, "auth_ref": [] }, "vsee_MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum consecutive days for suspension for use of resale registration statement.", "label": "Maximum Consecutive Days For Suspension For Use Of Resale Registration Statement", "terseLabel": "Maximum consecutive days for suspension for use of resale registration statement" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "auth_ref": [ "r403", "r404", "r405", "r406", "r491", "r529", "r601", "r696", "r780", "r781", "r792", "r825", "r826", "r886", "r888", "r890", "r891", "r893", "r914", "r915", "r939", "r948", "r957", "r966", "r967", "r971", "r972", "r988", "r1211", "r1287", "r1288", "r1289", "r1290", "r1291", "r1292" ] }, "vsee_MaximumTermForCarriedForwardOfAdjustmentsFromDateOfFirstEventForWarrants": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MaximumTermForCarriedForwardOfAdjustmentsFromDateOfFirstEventForWarrants", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum term for carried forward of adjustments from the date of first event for warrants.", "label": "Maximum Term for Carried Forward of Adjustments from The date of First Event for Warrants", "terseLabel": "Maximum term for carried forward of adjustments from the date of first event for warrants" } } }, "auth_ref": [] }, "vsee_MaximumValueOfSharesAgreedToBeIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MaximumValueOfSharesAgreedToBeIssued", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum value of shares agreed to be issued.", "label": "Maximum Value Of Shares Agreed To Be Issued", "terseLabel": "Maximum amount of shares issuable" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r1067" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1067" ] }, "vsee_MeasurementInputCccBondRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MeasurementInputCccBondRateMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to ccc bond rates.", "label": "Measurement Input CCC Bond Rate [Member]", "terseLabel": "CCC bond rates" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Discount Rate [Member]", "terseLabel": "Debt discount rate", "verboseLabel": "Principal discount factor", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Expected term (years)", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "us-gaap_MeasurementInputInceptionDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputInceptionDiscountRateMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Inception Discount Rate [Member]", "terseLabel": "Note calibration discount", "documentation": "Measurement input using interest rate at inception of contract to determine present value of future cash flows." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Volatility", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r966", "r1264", "r1265", "r1266" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Risk-free interest rate", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock price", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r599", "r600", "r601", "r966" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementAdditionalBridgeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExchangeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r599", "r600", "r601", "r966" ] }, "vsee_MedicalEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MedicalEquipmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal properties used in the field of medicine that are held by the entity.", "label": "Medical Equipment [Member]", "terseLabel": "Medical equipment" } } }, "auth_ref": [] }, "vsee_MiltonChenMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MiltonChenMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Co-CEO Milton Chen.", "label": "Milton Chen [Member]", "terseLabel": "Milton Chen" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "auth_ref": [ "r403", "r404", "r405", "r406", "r491", "r529", "r601", "r696", "r780", "r781", "r792", "r825", "r826", "r886", "r888", "r890", "r891", "r893", "r914", "r915", "r939", "r948", "r957", "r966", "r967", "r971", "r988", "r1211", "r1287", "r1288", "r1289", "r1290", "r1291", "r1292" ] }, "vsee_MinimumNoticePeriodForRedemptionOfNotes": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MinimumNoticePeriodForRedemptionOfNotes", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum notice period for redemption of notes.", "label": "Minimum Notice Period For Redemption Of Notes", "terseLabel": "Minimum notice period for redemption of notes" } } }, "auth_ref": [] }, "vsee_MinimumNoticePeriodForRedemptionOfWarrants": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MinimumNoticePeriodForRedemptionOfWarrants", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the Minimum notice period for redemption of Warrants.", "label": "Minimum Notice Period For Redemption Of Warrants", "terseLabel": "Minimum notice period for redemption of Warrants" } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r111", "r166", "r232", "r346", "r409", "r412", "r413", "r414", "r418", "r419", "r620", "r748", "r837" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Ownership Percentage, Parent", "terseLabel": "Ownership percentage", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r1087" ] }, "vsee_MonthlyRequiredOperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MonthlyRequiredOperatingLeasePayments", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of monthly required payments from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Monthly Required Operating Lease Payments", "terseLabel": "Monthly required lease payments" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r1095" ] }, "vsee_MunroTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "MunroTrustMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Munro Trust.", "label": "Munro Trust [Member]", "terseLabel": "Munro Trust" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "auth_ref": [ "r313", "r951", "r987", "r992", "r1215", "r1297", "r1298", "r1299", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r1068" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r224" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r224" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "terseLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r125", "r126", "r127" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "netLabel": "Net income (loss) attributable to stockholders", "totalLabel": "Net loss attributable to stockholders", "verboseLabel": "Net loss", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r118", "r127", "r169", "r198", "r214", "r215", "r219", "r232", "r243", "r245", "r246", "r248", "r249", "r250", "r254", "r255", "r261", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r566", "r576", "r595", "r620", "r757", "r855", "r876", "r877", "r1003", "r1207" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net profit attributable to non-controlling interest", "verboseLabel": "Non-controlling interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r82", "r156", "r214", "r215", "r250", "r254", "r255", "r756", "r1147" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r1067" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r1030", "r1041", "r1051", "r1075", "r1084" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1058" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1057" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r1075" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1095" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1095" ] }, "vsee_NonRule10b51ArrangementModifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NonRule10b51ArrangementModifiedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "N/A", "label": "Non Rule 10b5-1 Arrangement Modified Flag", "terseLabel": "Non-Rule 10b5-1 Arrangement Modified" } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Increase from Business Combination", "terseLabel": "Shares issued to non-controlling interest holders", "documentation": "Amount of increase in noncontrolling interest from a business combination." } } }, "auth_ref": [ "r11", "r63", "r74" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling Interest", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r79", "r469", "r1156", "r1157", "r1158", "r1161", "r1329" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense)", "terseLabel": "Total other income (expense)", "totalLabel": "Total other income (expense), net", "verboseLabel": "Other income (expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r120" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "verboseLabel": "Other income (expense)" } } }, "auth_ref": [] }, "vsee_NoteFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NoteFairValueAdjustment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of equity contract.", "label": "Note, Fair Value Adjustment", "terseLabel": "Change in fair value" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedAugust182023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedAugust182023Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note Payable issued August 18, 2023", "label": "Note Payable Issued August 18, 2023 [Member]", "verboseLabel": "Note payable issued August 18, 2023" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedAugust32023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedAugust32023Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note Payable issued August 3, 2023", "label": "Note Payable Issued August 3, 2023 [Member]", "verboseLabel": "Note Payable issued August 3, 2023" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedDecember12021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedDecember12021Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note payable issued December 1, 2021", "label": "Note Payable Issued December 1, 2021 [Member]", "verboseLabel": "Note payable issued December 1, 2021" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedJanuary122023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedJanuary122023Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note payable issued January 12, 2023", "label": "Note Payable Issued January 12, 2023 [Member]", "verboseLabel": "Note payable issued January 12, 2023" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedJanuary142024Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedJanuary142024Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note payable issued January 14, 2024", "label": "Note Payable Issued January 14, 2024 [Member]", "verboseLabel": "Note payable issued January 14, 2024" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember132023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedNovember132023Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note Payable issued November 13, 2023", "label": "Note Payable Issued November 13, 2023 [Member]", "verboseLabel": "Note payable issued November 13, 2023" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember212023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedNovember212023Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note payable issued November 21, 2023.", "label": "Note Payable Issued November 21, 2023 [Member]", "terseLabel": "Note payable issued November 21, 2023" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember292021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedNovember292021Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note payable issued November 29, 2021", "label": "Note Payable Issued November 29, 2021 [Member]", "verboseLabel": "Note payable issued November 29, 2021" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember292023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotePayableIssuedNovember292023Member", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Note payable issued November 29, 2023", "label": "Note Payable Issued November 29, 2023 [Member]", "terseLabel": "Note payable issued November 29, 2023" } } }, "auth_ref": [] }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesAndLoansReceivableGrossNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "terseLabel": "Note receivable with principal balance", "documentation": "Amortized cost, before allowance for credit loss, of financing receivable classified as noncurrent. Excludes net investment in lease." } } }, "auth_ref": [ "r1173", "r1184" ] }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesAndLoansReceivableNetNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Note receivable, related party", "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent." } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Current", "terseLabel": "Notes payable, current portion", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r96", "r97" ] }, "vsee_NotesPayableCurrentNetOfDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotesPayableCurrentNetOfDiscount", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer, net of discount.", "label": "Notes Payable, Current, Net of Discount", "terseLabel": "Notes payable, net of discount" } } }, "auth_ref": [] }, "vsee_NotesReceivableAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NotesReceivableAllowanceForCreditLossWriteoff", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of notes receivable charged against the allowance.", "label": "Notes Receivable, Allowance for Credit Loss, Writeoff", "terseLabel": "Note receivable write-off" } } }, "auth_ref": [] }, "us-gaap_NotesReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NotesReduction", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Notes Reduction", "terseLabel": "Shares issued as principal payment of notes", "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "vsee_NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation.", "label": "Number Of Deployed Telepresence Robots Rights Considered For Calculating Percentage of Monthly Revenue Generation", "terseLabel": "Telepresence robots deployed" } } }, "auth_ref": [] }, "vsee_NumberOfDeployedTelepresenceRobotsRightsHeld": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfDeployedTelepresenceRobotsRightsHeld", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of deployed telepresence robots for which rights are held by the related party.", "label": "Number Of Deployed Telepresence Robots Rights Held", "terseLabel": "Number of deployed telepresence robots rights held" } } }, "auth_ref": [] }, "vsee_NumberOfFractionalSharesThatWillBeIssuedUponExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfFractionalSharesThatWillBeIssuedUponExerciseOfWarrants", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of fractional shares that will be issued upon exercise of warrants", "label": "Number Of Fractional Shares That Will Be Issued Upon Exercise Of Warrants", "terseLabel": "Number of fractional shares that will be issued upon exercise of warrants" } } }, "auth_ref": [] }, "vsee_NumberOfLegacyOperatingEntities": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfLegacyOperatingEntities", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of legacy operating entities.", "label": "Number Of Legacy Operating Entities", "terseLabel": "Number of legacy operating entities" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Number of Operating Segments", "terseLabel": "Number of operating segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r934", "r1165" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportableSegments", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r928", "r938", "r1165" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfReportingUnits", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Number of Reporting Units", "terseLabel": "Number of reporting units", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [] }, "vsee_NumberOfSharesAllocated": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfSharesAllocated", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares allocated for the Series A Preferred.", "label": "Number Of Shares Allocated", "terseLabel": "Number of shares allocated" } } }, "auth_ref": [] }, "vsee_NumberOfTopCustomers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfTopCustomers", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of top customers of the company.", "label": "Number Of Top Customers", "terseLabel": "Number of top customers" } } }, "auth_ref": [] }, "vsee_NumberOfVotesPerShare": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "NumberOfVotesPerShare", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of votes that each share entitles the holder.", "label": "Number of Votes Per Share", "terseLabel": "Number of vote per share" } } }, "auth_ref": [] }, "vsee_OfficeAndMedicalEquipmentFurnitureMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OfficeAndMedicalEquipmentFurnitureMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office or medical setting as well as furniture.", "label": "Office and Medical Equipment, Furniture [Member]", "terseLabel": "Office, medical equipment, and furniture" } } }, "auth_ref": [] }, "vsee_OfficeAndMedicalEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OfficeAndMedicalEquipmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office or medical setting.", "label": "Office and Medical Equipment [Member]", "terseLabel": "Office and medical equipment" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OfficeEquipmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Office Equipment [Member]", "terseLabel": "Office equipment", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "vsee_OfficeSpaceInHoustonMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OfficeSpaceInHoustonMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to the office space leased in Houston.", "label": "Office Space In Houston [Member]", "terseLabel": "Office space in Houston" } } }, "auth_ref": [] }, "vsee_OfficeSpaceInTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OfficeSpaceInTexasMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to the office space leased in Texas.", "label": "Office Space In Texas [Member]", "terseLabel": "Office space in Texas" } } }, "auth_ref": [] }, "vsee_OneCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OneCustomerMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to the one \ncustomer.", "label": "One Customer [Member]", "terseLabel": "One customer" } } }, "auth_ref": [] }, "vsee_OneOfLendersUnderArLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OneOfLendersUnderArLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to one of the lenders under A&R Loan Conversion SPAs.", "label": "One of The Lenders Under AR Loan Conversion Spas [Member]", "terseLabel": "One of the lenders under A&R Loan Conversion SPAs" } } }, "auth_ref": [] }, "vsee_OneVendorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OneVendorMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to one vendor.", "label": "One Vendor [Member]", "terseLabel": "One vendor" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Expenses", "terseLabel": "Operating expense", "totalLabel": "Total operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "terseLabel": "Total loss from operations", "totalLabel": "Net operating loss", "verboseLabel": "Net operating loss", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r173", "r927", "r1164", "r1166", "r1168", "r1169", "r1170" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails": { "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Operating lease expense", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r643", "r975" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Expense", "totalLabel": "Total operating lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r1276" ] }, "vsee_OperatingLeaseFifthRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseFifthRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the fifth specified rental period under the operating lease.", "label": "Operating Lease, Fifth Rental Period [Member]", "terseLabel": "Fifth rental period" } } }, "auth_ref": [] }, "vsee_OperatingLeaseFirstRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseFirstRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the first specified rental period under the operating lease.", "label": "Operating Lease, First Rental Period [Member]", "terseLabel": "First rental period" } } }, "auth_ref": [] }, "vsee_OperatingLeaseFourthRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseFourthRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the fourth specified rental period under the operating lease.", "label": "Operating Lease, Fourth Rental Period [Member]", "terseLabel": "Fourth rental period" } } }, "auth_ref": [] }, "vsee_OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of operating lease liabilities that are included in accounts payable and accrued liabilities at balance sheet date.", "label": "Operating Lease Liabilities Included In Accounts Payable And Accrued Liabilities", "terseLabel": "Operating lease liabilities included in accounts payable and accrued liabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]", "terseLabel": "Operating Lease - Future minimum rent payments" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseFutureMinimumRentPaymentsDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "terseLabel": "Present value of payments", "totalLabel": "Office lease", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r635" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "negatedLabel": "Less: Current portion", "positiveLabel": "Operating lease liabilities", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r635" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "positiveLabel": "Operating lease liabilities, less current portion", "terseLabel": "Long-term portion", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r635" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeaseLiabilitiesDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Office space lease payments", "verboseLabel": "Operating lease cash payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r639", "r644" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "positiveLabel": "Right-of-use assets, net", "totalLabel": "Right-of-use assets, net", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r634" ] }, "vsee_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails": { "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, Accumulated Amortization", "negatedLabel": "Less: Accumulated amortization" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails": { "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of right-of-use asset from operating lease.", "label": "Operating Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Office lease" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseAssetReductionFromContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseRightOfUseAssetReductionFromContractTermination", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of reduction of operating lease right of use asset due to termination of lease.", "label": "Operating Lease Right Of Use Asset, Reduction From Contract Termination", "terseLabel": "Right of use asset relieved due to termination of lease" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseLiabilityReductionFromContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseRightOfUseLiabilityReductionFromContractTermination", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of reduction of operating lease right of use liability due to termination of lease.", "label": "Operating Lease Right Of Use Liability, Reduction From Contract Termination", "terseLabel": "Right of use liability relieved due to termination of lease" } } }, "auth_ref": [] }, "vsee_OperatingLeaseSecondRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseSecondRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the second specified rental period under the operating lease.", "label": "Operating Lease, Second Rental Period [Member]", "terseLabel": "Second rental period" } } }, "auth_ref": [] }, "vsee_OperatingLeaseThirdRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLeaseThirdRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the third specified rental period under the operating lease.", "label": "Operating Lease, Third Rental Period [Member]", "terseLabel": "Third rental period" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted average discount rate", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r646", "r975" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasePaymentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted average remaining lease term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r645", "r975" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r553" ] }, "vsee_OperatingLossCarryforwardsUtilized": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OperatingLossCarryforwardsUtilized", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward utilized.", "label": "Operating Loss Carryforwards Utilized", "terseLabel": "Amount of operating loss carryforward" } } }, "auth_ref": [] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingSegmentsMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "terseLabel": "Operating segments", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r299", "r300", "r301", "r302", "r303", "r306", "r933", "r934" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization and Description of Business" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusiness" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization and Description of Business", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r94", "r155", "r794", "r795" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Consolidation", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r128", "r129", "r130", "r155" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r97" ] }, "vsee_OtherCurrentDhacShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OtherCurrentDhacShareholdersMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to other current DHAC shareholders.", "label": "Other Current DHAC Shareholders [Member]", "terseLabel": "Other Current DHAC Shareholders" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "terseLabel": "Due to related party", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r97", "r976" ] }, "us-gaap_OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Liability, Current, Related Party [Extensible Enumeration]", "documentation": "Indicates status and type of related party for liability classified as other and current." } } }, "auth_ref": [ "r1284" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net", "verboseLabel": "Other income", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r122" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1067" ] }, "us-gaap_OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Receivable, after Allowance for Credit Loss, Current, Related Party [Extensible Enumeration]", "terseLabel": "Other Receivable, after Allowance for Credit Loss, Current, Related Party [Extensible Enumeration]", "documentation": "Indicates status and type of related party for receivable, after allowance for credit loss, classified as other and current." } } }, "auth_ref": [ "r1284" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Receivables, Net, Current", "terseLabel": "Due from related party", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1028", "r1039", "r1049", "r1082" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r1031", "r1042", "r1052", "r1085" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1031", "r1042", "r1052", "r1085" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipAxis", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "vsee_OwnershipChangeTestingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "OwnershipChangeTestingPeriod", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The period used to test changes in stock ownership, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Ownership Change, Testing Period", "terseLabel": "Ownership change, testing period" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipDomain", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1056" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities" } } }, "auth_ref": [] }, "vsee_PaymentOfBusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PaymentOfBusinessCombinationAcquisitionRelatedCosts", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow pertaining to business acquisition related costs.", "label": "Payment Of Business Combination Acquisition Related Costs", "terseLabel": "Payment of acquisition related costs" } } }, "auth_ref": [] }, "vsee_PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligationIncludingGuaranteedMinimumInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligationIncludingGuaranteedMinimumInterest", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the payments for optional prepayment as percentage of outstanding obligation including guaranteed minimum interest.", "label": "Payments For Optional Prepayment As Percentage Of Outstanding Obligation Including Guaranteed Minimum Interest", "terseLabel": "Payments for optional prepayment as percentage of outstanding obligation including guaranteed minimum interest (in percentage)" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfMergerRelatedCostsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfMergerRelatedCostsFinancingActivities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Merger Related Costs, Financing Activities", "negatedLabel": "Payments on due on acquisition purchase", "documentation": "The cash outflow for financing costs associated with business combinations." } } }, "auth_ref": [ "r23" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEncompassPurchaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "verboseLabel": "Encompass for a cash payment", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r21", "r572" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Productive Assets", "terseLabel": "Capital expenditures", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r178", "r1255", "r1256", "r1257" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of fixed assets", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r123" ] }, "vsee_PaymentsToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PaymentsToRelatedParties", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to related parties during the period.", "label": "Payments to Related Parties", "terseLabel": "Payments to related parties" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r1066" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1066" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1058" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r1075" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r1068" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1057" ] }, "vsee_PercentageOfAllowableDeductionOfTaxableIncome": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PercentageOfAllowableDeductionOfTaxableIncome", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of allowable deduction of taxable income.", "label": "Percentage Of Allowable Deduction Of Taxable Income", "terseLabel": "Percentage of allowable deduction of taxable income" } } }, "auth_ref": [] }, "vsee_PercentageOfMinimumIncreaseOrDecreaseInAggregateNumberOfCommonSharesPurchasableUponExerciseOfAllWarrantsConsideredForAdjustmentToSharesReceivableUponExerciseOfEachWarrant": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PercentageOfMinimumIncreaseOrDecreaseInAggregateNumberOfCommonSharesPurchasableUponExerciseOfAllWarrantsConsideredForAdjustmentToSharesReceivableUponExerciseOfEachWarrant", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of minimum increase or decrease in aggregate number of common shares purchasable upon exercise of all warrants considered for adjustment to shares receivable upon exercise of each warrant.", "label": "Percentage Of Minimum Increase Or Decrease In Aggregate Number Of Common Shares Purchasable Upon Exercise Of All Warrants Considered For Adjustment To Shares Receivable Upon Exercise Of Each Warrant", "terseLabel": "Percentage of increase or decrease in aggregate number of common shares purchasable upon exercise of all warrants considered for adjustment to shares receivable upon exercise of each warrant" } } }, "auth_ref": [] }, "vsee_PercentageOfMonthlyRevenueGeneratedFromTelepresenceRobotsConsideredForPaymentsOnPromissoryNote": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PercentageOfMonthlyRevenueGeneratedFromTelepresenceRobotsConsideredForPaymentsOnPromissoryNote", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of monthly revenue generated on eight telepresence robots, based on which company is required to make payments to the related party on promissory note.", "label": "Percentage of Monthly Revenue Generated from Telepresence Robots, Considered for Payments on Promissory Note", "terseLabel": "Percentage of monthly revenue generated from telepresence robots, considered for payment" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PerformanceSharesMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Performance Shares [Member]", "terseLabel": "Performance shares", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "vsee_PeriodAgreedToFileResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PeriodAgreedToFileResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period agreed to file a resale registration statement.", "label": "Period Agreed To File Resale Registration Statement", "terseLabel": "Period agreed to file a resale registration statement" } } }, "auth_ref": [] }, "vsee_PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period within which registration statement shall be declared effective.", "label": "Period Within Which Registration Statement Shall Be Declared Effective", "terseLabel": "Period within which registration statement shall be declared effective" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1217", "r1218", "r1219", "r1220", "r1221", "r1222", "r1223", "r1224", "r1225", "r1226", "r1227", "r1228", "r1229", "r1230", "r1231", "r1232", "r1233", "r1234", "r1235", "r1236", "r1237", "r1238", "r1239", "r1240", "r1241", "r1242" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1217", "r1218", "r1219", "r1220", "r1221", "r1222", "r1223", "r1224", "r1225", "r1226", "r1227", "r1228", "r1229", "r1230", "r1231", "r1232", "r1233", "r1234", "r1235", "r1236", "r1237", "r1238", "r1239", "r1240", "r1241", "r1242" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r1059" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r1115" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r1058" ] }, "vsee_PreferredStockConvertibleAlternateConversionMeasuringPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockConvertibleAlternateConversionMeasuringPeriod", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the alternate conversion measuring period for conversion of preferred stock.", "label": "Preferred Stock, Convertible, Alternate Conversion Measuring Period", "terseLabel": "Alternate conversion measuring period" } } }, "auth_ref": [] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Convertible, Conversion Price", "terseLabel": "Preferred stock, conversion rate (in dollars per share)", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r454" ] }, "vsee_PreferredStockConvertibleConversionPricePercentageUsedForCalculation": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockConvertibleConversionPricePercentageUsedForCalculation", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage used for calculation of conversion price of convertible preferred stock.", "label": "Preferred Stock, Convertible, Conversion Price, Percentage used for Calculation", "terseLabel": "Percentage used for calculation of conversion price" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockConvertibleTerm", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and conversion of preferred stock, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Preferred Stock, Convertible, Term", "terseLabel": "Preferred stock, convertible term" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockConvertibleThresholdConsecutiveTradingDays", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of preferred stock must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Preferred Stock, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Threshold period of specified consecutive trading days" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockConvertibleThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of preferred stock must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Preferred Stock, Convertible, Threshold Trading Days", "terseLabel": "Threshold number of specified trading days" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of preferred stock issued as a settlement of debt during the period pursuant to acquisitions.", "label": "Preferred Stock Issued During Period, Shares, Settlement of Debt As A Part of Consideration in Acquisitions", "terseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition (in shares)" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodSharesSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockIssuedDuringPeriodSharesSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of preferred stock issued as a settlement of underwriting fee during the period pursuant to acquisitions.", "label": "Preferred Stock Issued During Period, Shares, Settlement of Underwriting Fee As A Part of Consideration in Acquisitions", "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction (in shares)" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of preferred stock issued to settle debt pursuant to consideration in acquisitions during the period.", "label": "Preferred Stock Issued During Period, Value, Settlement of Debt As A Part of Consideration in Acquisition", "terseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of preferred stock issued to settle underwriting fee pursuant to consideration in acquisitions during the period.", "label": "Preferred Stock Issued During Period, Value, Settlement of Underwriting Fee As A Part of Consideration in Acquisition", "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction" } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r995", "r996", "r999", "r1000", "r1001", "r1002", "r1326", "r1329" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r106", "r452" ] }, "us-gaap_PreferredStockRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockRedemptionPricePerShare", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Redemption Price Per Share", "terseLabel": "Redemption price per share", "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer." } } }, "auth_ref": [ "r57", "r58", "r61" ] }, "vsee_PreferredStockRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockRedemptionPricePercentage", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of stated value of shares at which preferred stock can be redeemed.", "label": "Preferred Stock, Redemption Price, Percentage", "terseLabel": "Percentage of redemption price" } } }, "auth_ref": [] }, "vsee_PreferredStockRedemptionRights": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PreferredStockRedemptionRights", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the redemption of rights of preferred stock.", "label": "Preferred Stock, Redemption Rights", "terseLabel": "Redemption rights of preferred stock" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r106", "r835" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r106", "r452" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r106", "r835", "r853", "r1329", "r1330" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 6,158 and 0 shares issued and outstanding as of December 31, 2024 and 2023, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r106", "r745", "r976" ] }, "vsee_PrepaidAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PrepaidAssetsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for prepaid assets.", "label": "Prepaid Assets [Policy Text Block]", "terseLabel": "Prepaid Assets and Other Current Assets" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaids and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1146" ] }, "us-gaap_PriorPeriodAdjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PriorPeriodAdjustmentAbstract", "lang": { "en-us": { "role": { "label": "Restatement of Previously Issued Financial Statements" } } }, "auth_ref": [] }, "vsee_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to private placement warrants.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private placement warrants" } } }, "auth_ref": [] }, "vsee_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PrivateWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Private warrants.", "label": "Private Warrants [Member]", "terseLabel": "Private Warrants" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from convertible debt", "verboseLabel": "Proceeds from convertible note", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Debt", "terseLabel": "Cash proceeds received", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r1149" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from note payable", "verboseLabel": "Proceeds from debt", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from loan payable, related party", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r22" ] }, "vsee_ProceedsFromReverseRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ProceedsFromReverseRecapitalization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from a reverse recapitalization.", "label": "Proceeds From Reverse Recapitalization", "terseLabel": "Proceeds from reverse recapitalization with DHAC" } } }, "auth_ref": [] }, "vsee_ProceedsFromShareRepurchaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ProceedsFromShareRepurchaseLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from the recognition of liability under share repurchase program.", "label": "Proceeds From Share Repurchase Liability", "terseLabel": "Proceeds from share repurchase liability" } } }, "auth_ref": [] }, "vsee_ProceedsFromSubscriptionsOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ProceedsFromSubscriptionsOfCommonStock", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash inflow received for common stock subscriptions during the period.", "label": "Proceeds From Subscriptions of Common Stock", "terseLabel": "Employee subscription of shares in cash" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r309", "r701", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r918", "r949", "r986", "r988", "r989", "r993", "r994", "r1204", "r1205", "r1215", "r1297", "r1298", "r1299", "r1300", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r309", "r701", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r918", "r949", "r986", "r988", "r989", "r993", "r994", "r1204", "r1205", "r1215", "r1297", "r1298", "r1299", "r1300", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "us-gaap_ProfessionalAndContractServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfessionalAndContractServicesExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Professional and Contract Services Expense", "terseLabel": "Consulting expense recognized", "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support." } } }, "auth_ref": [] }, "vsee_ProfessionalServicesAndOtherFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ProfessionalServicesAndOtherFeesMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents fees relating to professional and other services.", "label": "Professional Services And Other Fees [Member]", "terseLabel": "Professional services and other fees" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net loss", "verboseLabel": "Net loss", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r198", "r214", "r215", "r223", "r232", "r243", "r250", "r254", "r255", "r346", "r409", "r410", "r412", "r413", "r414", "r415", "r416", "r418", "r419", "r566", "r576", "r577", "r580", "r581", "r595", "r620", "r737", "r755", "r809", "r855", "r876", "r877", "r960", "r961", "r1004", "r1147", "r1207" ] }, "vsee_PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to promissory note and line of credit relating to forbearance agreement.", "label": "Promissory Note and Line of Credit Relating to Forbearance Agreement [Member]", "terseLabel": "Promissory note and line of credit" } } }, "auth_ref": [] }, "vsee_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Promissory Note [Member]", "label": "Promissory Note [Member]", "terseLabel": "Promissory Note" } } }, "auth_ref": [] }, "vsee_PromissoryNoteWithRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PromissoryNoteWithRelatedPartyMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note With Related Party [Member]", "terseLabel": "Promissory note with related party" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Fixed Assets" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5", "r648" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Fixed Assets", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r132", "r183", "r188", "r189" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://vseehealth.com/role/DisclosureFixedAssetsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "terseLabel": "Fixed Assets, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r133", "r202", "r753" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Fixed Assets", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r648" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 }, "http://vseehealth.com/role/DisclosureFixedAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net", "terseLabel": "Fixed assets, net", "totalLabel": "Fixed assets, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r648", "r738", "r753", "r976" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Fixed Assets", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r5", "r183", "r188", "r751" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsTables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of components of fixed assets", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r133", "r648" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Useful life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAccountsReceivableAndCreditLossesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "verboseLabel": "Provision for credit losses", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r221", "r355" ] }, "vsee_PublicAndPrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PublicAndPrivateWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to public and private warrants.", "label": "Public And Private Warrants [Member]", "terseLabel": "Public And Private Warrants" } } }, "auth_ref": [] }, "vsee_PublicStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PublicStockholdersMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to public stockholders.", "label": "Public Stockholders [Member]", "verboseLabel": "Public stockholders formerly DHAC" } } }, "auth_ref": [] }, "vsee_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PublicWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to public warrants.", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementForTelepresenceRobotsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PurchaseAgreementForTelepresenceRobotsMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to purchase of Telepresence Robots.", "label": "Purchase Agreement for Telepresence Robots [Member]", "terseLabel": "Purchase Agreement for Telepresence Robots" } } }, "auth_ref": [] }, "vsee_PurchaseCommitmentAdjustmentsAndPaymentsMade": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "PurchaseCommitmentAdjustmentsAndPaymentsMade", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of adjustments and payments made to the purchase commitment.", "label": "Purchase Commitment, Adjustments And Payments Made", "terseLabel": "Purchase commitment amount, payments made" } } }, "auth_ref": [] }, "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Purchase Commitment, Remaining Minimum Amount Committed", "terseLabel": "Purchase commitment amount", "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations." } } }, "auth_ref": [ "r102", "r165" ] }, "us-gaap_PurchaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PurchaseObligation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Purchase Obligation", "terseLabel": "Purchase obligation remaining", "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1056" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r1056" ] }, "vsee_QuantumInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "QuantumInvestorMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Quantum Investor.", "label": "Quantum Investor [Member]", "terseLabel": "Quantum Investor" } } }, "auth_ref": [] }, "vsee_QuantumNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "QuantumNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementQuantumConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Quantum Note.", "label": "Quantum Note [Member]", "terseLabel": "Quantum Convertible Note", "verboseLabel": "Quantum Convertible Note, related party" } } }, "auth_ref": [] }, "vsee_QuantumNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "QuantumNotesMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to quantum note.", "label": "Quantum Notes [Member]", "terseLabel": "Quantum Convertible Note, related party at fair value", "verboseLabel": "Quantum Convertible Note" } } }, "auth_ref": [] }, "vsee_QuantumPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "QuantumPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to quantum purchase agreement.", "label": "Quantum Purchase Agreement [Member]", "terseLabel": "Quantum Purchase Agreement" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r403", "r404", "r405", "r406", "r483", "r491", "r519", "r520", "r521", "r529", "r601", "r670", "r679", "r696", "r780", "r781", "r792", "r825", "r826", "r886", "r888", "r890", "r891", "r893", "r914", "r915", "r939", "r948", "r957", "r966", "r967", "r971", "r972", "r988", "r997", "r1203", "r1211", "r1265", "r1288", "r1289", "r1290", "r1291", "r1292" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r403", "r404", "r405", "r406", "r483", "r491", "r519", "r520", "r521", "r529", "r601", "r670", "r679", "r696", "r780", "r781", "r792", "r825", "r826", "r886", "r888", "r890", "r891", "r893", "r914", "r915", "r939", "r948", "r957", "r966", "r967", "r971", "r972", "r988", "r997", "r1203", "r1211", "r1265", "r1288", "r1289", "r1290", "r1291", "r1292" ] }, "vsee_ReceivablesCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ReceivablesCreditLossExpenseReversal", "crdr": "debit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on receivables.", "label": "Receivables, Credit Loss Expense (Reversal)", "terseLabel": "Allowance for expected credit losses" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Summary of reportable segment total assets", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets." } } }, "auth_ref": [ "r45", "r46" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Abstract]", "terseLabel": "Reconciliation to income (loss) before income taxes:" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r44", "r46" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Schedule of reconciliation of consolidated segment operating income to consolidated earnings before taxes", "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r44", "r46" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r1023", "r1034", "r1044", "r1077" ] }, "vsee_RelatedPartyAgreementExtensionTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RelatedPartyAgreementExtensionTerm", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Term of the extension of the agreement with related party.", "label": "Related Party, Agreement Extension Term", "terseLabel": "Extension term" } } }, "auth_ref": [] }, "vsee_RelatedPartyAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RelatedPartyAgreementTerm", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Term of the agreement with related party.", "label": "Related Party, Agreement Term", "terseLabel": "Agreement term" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r314", "r490", "r655", "r656", "r743", "r750", "r828", "r829", "r830", "r831", "r832", "r852", "r854", "r885" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "terseLabel": "Related party", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r234", "r235", "r655", "r656", "r657", "r658", "r743", "r750", "r828", "r829", "r830", "r831", "r832", "r852", "r854", "r885" ] }, "vsee_RelatedPartyPromissoryNoteOneMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RelatedPartyPromissoryNoteOneMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Related party promissory note one.", "label": "Related Party Promissory Note One [Member]", "terseLabel": "Promissory note one" } } }, "auth_ref": [] }, "vsee_RelatedPartyPromissoryNoteThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RelatedPartyPromissoryNoteThreeMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Related party promissory note three.", "label": "Related Party Promissory Note Three [Member]", "terseLabel": "Promissory note three" } } }, "auth_ref": [] }, "vsee_RelatedPartyPromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RelatedPartyPromissoryNoteTwoMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Related party promissory note two.", "label": "Related Party Promissory Note Two [Member]", "terseLabel": "Promissory note two" } } }, "auth_ref": [] }, "vsee_RelatedPartyTransactionAmountsOfTransactionPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RelatedPartyTransactionAmountsOfTransactionPerMonth", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party per month during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction Per Month", "terseLabel": "Expense per month" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r655", "r656", "r1284" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r314", "r859", "r860", "r863" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction, Rate", "terseLabel": "Interest rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r314", "r490", "r655", "r656", "r743", "r750", "r828", "r829", "r830", "r831", "r832", "r852", "r854", "r885", "r1284" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedParty" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r652", "r653", "r654", "r656", "r659", "r805", "r806", "r807", "r861", "r862", "r863", "r882", "r884" ] }, "vsee_RepaymentOnFactoringPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RepaymentOnFactoringPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow to settle factoring payable during the year.", "label": "Repayment On Factoring Payable", "negatedLabel": "Payments on factoring payable" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfConvertibleDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Convertible Debt", "negatedLabel": "Payments on September 2024 Convertible Note", "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r124" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Notes Payable", "negatedLabel": "Repayment of notes payable", "terseLabel": "Repayments of notes payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r124" ] }, "vsee_RepaymentsOfNotesPayablePrincipalPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RepaymentsOfNotesPayablePrincipalPortion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow for the principal portion of a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable, Principal Portion", "terseLabel": "Repayments of notes payable, principal portion" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Related Party Debt", "negatedLabel": "Payments on advances from related party", "terseLabel": "Advances repaid", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r124" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r236", "r237", "r424", "r455", "r658", "r680", "r740", "r922", "r923" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementAxis", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r196", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r251", "r252", "r253", "r254", "r255", "r256", "r267", "r348", "r349", "r564", "r565", "r566", "r567", "r575", "r576", "r592", "r593", "r594", "r595", "r630", "r632", "r650", "r651", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r796", "r1171" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r1024", "r1035", "r1045", "r1078" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r1025", "r1036", "r1046", "r1079" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r1032", "r1043", "r1053", "r1086" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RestatementDomain", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r196", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r251", "r252", "r253", "r254", "r255", "r256", "r267", "r348", "r349", "r564", "r565", "r566", "r567", "r575", "r576", "r592", "r593", "r594", "r595", "r630", "r632", "r650", "r651", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r796", "r1171" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r109", "r141", "r747", "r786", "r791", "r803", "r836", "r976" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r195", "r240", "r241", "r242", "r244", "r250", "r253", "r255", "r347", "r350", "r394", "r555", "r556", "r563", "r564", "r565", "r567", "r575", "r576", "r584", "r586", "r587", "r589", "r593", "r631", "r633", "r782", "r784", "r810", "r1329" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenues", "verboseLabel": "Revenues", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r171", "r172", "r268", "r277", "r278", "r299", "r305", "r309", "r311", "r313", "r480", "r481", "r701" ] }, "us-gaap_RevenueFromContractWithCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue", "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r313", "r1124" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r192", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r917" ] }, "vsee_RevenueRecognitionNoticePeriodForCancelationOfContract": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RevenueRecognitionNoticePeriodForCancelationOfContract", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Period within which notice is required for cancellation of contract with customers for generation of revenue.", "label": "Revenue Recognition, Notice Period For Cancelation Of Contract", "terseLabel": "Notice period for cancelation of contract" } } }, "auth_ref": [] }, "vsee_RevenueRecognitionTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "RevenueRecognitionTermOfContract", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Term of the contract for revenues generated by the company.", "label": "Revenue Recognition, Term Of Contract", "terseLabel": "Term of contract" } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue expects to recognize", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r186" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue excepted timing of satisfaction period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r187" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r187" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues" } } }, "auth_ref": [] }, "vsee_ReversalOfBusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ReversalOfBusinessCombinationAcquisitionRelatedCosts", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of reversal of business combination related acquisition costs.", "label": "Reversal Of Business Combination Acquisition Related Costs", "terseLabel": "Decrease in transaction expenses" } } }, "auth_ref": [] }, "vsee_ReversalOfBusinessCombinationAcquisitionRelatedStockBasedCompensationExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ReversalOfBusinessCombinationAcquisitionRelatedStockBasedCompensationExpenses", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of reversal of business combination related acquisition cost to share-based compensation expense.", "label": "Reversal Of Business Combination Acquisition Related Stock Based Compensation Expenses", "terseLabel": "Decrease the stock-based compensation expense" } } }, "auth_ref": [] }, "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Error Correction, Adjustment [Member]", "terseLabel": "Adjustment" } } }, "auth_ref": [ "r245", "r246", "r247", "r252", "r253", "r254", "r255" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Line of credit", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1095" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1095" ] }, "vsee_Rule10b51ArrangementModifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "Rule10b51ArrangementModifiedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "documentation": "N/A", "label": "Rule 10b5-1 Arrangement Modified Flag", "terseLabel": "Rule 10b5-1 Arrangement Modified" } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskOtherMattersDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Excise tax payable", "verboseLabel": "Sales and use taxes", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r95" ] }, "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Sales and Excise Tax Payable", "terseLabel": "Accrued sales and use tax", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax." } } }, "auth_ref": [ "r163" ] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "As Reported" } } }, "auth_ref": [ "r196", "r240", "r242", "r243", "r244", "r245", "r246", "r255", "r267", "r564", "r566", "r567", "r575", "r576", "r592", "r593", "r594", "r630", "r632", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r796", "r1128", "r1131", "r1132", "r1133", "r1159", "r1171", "r1182", "r1183", "r1260", "r1280", "r1281" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r256", "r492", "r1120", "r1160" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureAccountsPayableAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of components of accounts payable and accrued liabilities", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Security, Excluded EPS Calculation [Table]", "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table Text Block]", "terseLabel": "Summary of purchase consideration for iDoc acquisition", "documentation": "Tabular disclosure of the equity interest issued or issuable in a business acquisition (or series of individually immaterial business acquisitions) planned, initiated, or completed during the period." } } }, "auth_ref": [ "r154" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPreliminaryAllocationOfTotalPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationTables", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r68", "r71", "r570" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "verboseLabel": "Schedule of income tax provision", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r1252" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of notes payable", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "verboseLabel": "Schedule of deferred tax assets and liabilities", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r1249" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of potentially dilutive shares", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1163" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "verboseLabel": "Summary of reconciliation of the federal income tax rate to the Company's effective tax rate", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r538", "r959", "r1246" ] }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Error Correction [Table]", "documentation": "Disclosure of information about prior period adjustment to correct error in previously issued financial statement. Includes, but is not limited to, effect of correction on financial statement line item, affected per-share amount, cumulative effect of change on retained earnings and other appropriate component of equity or net assets in statement of financial position, and effect of prior period adjustment on net income of each prior period presented." } } }, "auth_ref": [ "r245", "r246", "r247", "r252", "r253", "r254", "r255", "r267" ] }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]", "terseLabel": "Tabular disclosure of the effect of the restatement items on each financial statement line items", "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Identifiable intangible assets subject to amortization", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r942", "r1194" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of required principal payments of notes payable and line of credit", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r6" ] }, "vsee_ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of common stock outstanding following the consummation of business combination.", "label": "Schedule of Number of Common stock Outstanding after Business Combination [Table Text Block]", "terseLabel": "Schedule of Common stock Business Combination" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://vseehealth.com/role/DisclosureFixedAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5", "r648" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of the assets acquired and liabilities assumed as part of the business combination", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r151" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r89", "r90", "r859", "r860", "r863" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r41", "r42", "r43" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of segment reporting information", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r41", "r42", "r43" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureEquityTables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of stock options activity", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r15", "r16", "r143" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of the key assumptions used in valuing the unvested options", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r145" ] }, "us-gaap_ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSharesSubjectToMandatoryRedemptionBySettlementTermsAxis", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Schedule of Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Axis]", "documentation": "Information by financial instrument subject to mandatory redemption." } } }, "auth_ref": [ "r7", "r12", "r53" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationSummaryOfRecapitalizationAndNetEquityDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Stock, Class of Stock [Table]", "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks." } } }, "auth_ref": [ "r55", "r56", "r58", "r59", "r60", "r62", "r137", "r139", "r140", "r141", "r209", "r210", "r211", "r270", "r452", "r453", "r455", "r457", "r460", "r465", "r467", "r799", "r800", "r801", "r802", "r948", "r1119", "r1151" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrants issued and outstanding", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r64" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of expected amortization expense", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r942", "r1196" ] }, "vsee_ScsCapitalPartnersLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ScsCapitalPartnersLlcMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to SCS Capital Partners LLC .", "label": "SCS Capital Partners LLC [Member]", "terseLabel": "SCS Capital Partners LLC" } } }, "auth_ref": [] }, "vsee_Section382LimitationAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "Section382LimitationAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of Section 382 limitation with respect to ownership change.", "label": "Section 382 Limitation, Amount", "terseLabel": "Section 382 limitation amount" } } }, "auth_ref": [] }, "vsee_SecuredPromissoryNoteIssuedOnMarch202025Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SecuredPromissoryNoteIssuedOnMarch202025Member", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to secured promissory note issued March 20, 2025.", "label": "Secured Promissory Note Issued on March 20, 2025 [Member]", "terseLabel": "Secured promissory note issued on March 20, 2025" } } }, "auth_ref": [] }, "us-gaap_SecuritiesSubjectToMandatoryRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuritiesSubjectToMandatoryRedemptionMember", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Securities Subject to Mandatory Redemption [Member]", "terseLabel": "Securities Subject to Mandatory Redemption", "documentation": "Securities issued in the form of shares that embody an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur." } } }, "auth_ref": [ "r7", "r12" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1006" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1008" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentDomain", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r171", "r172", "r173", "r174", "r268", "r273", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r289", "r290", "r291", "r299", "r300", "r301", "r302", "r303", "r305", "r306", "r307", "r313", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r392", "r401", "r402", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r930", "r933", "r934", "r941", "r991", "r1297", "r1298", "r1299", "r1300", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "SegmentGeographicalDomain", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "auth_ref": [ "r311", "r312", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r822", "r823", "r824", "r887", "r889", "r892", "r894", "r902", "r904", "r905", "r906", "r907", "r909", "r910", "r911", "r912", "r913", "r919", "r950", "r978", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r990", "r997", "r1215", "r1297", "r1298", "r1299", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Reportable Segments" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegments" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Reportable Segments", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r174", "r268", "r272", "r273", "r274", "r275", "r276", "r288", "r290", "r291", "r303", "r304", "r305", "r306", "r307", "r309", "r310", "r313", "r928", "r931", "r932", "r933", "r935", "r937", "r938" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "terseLabel": "Reportable segments", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segments", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r308", "r311", "r929", "r930", "r936" ] }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "terseLabel": "Reportable Segments", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SeniorNotesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotesCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Senior Notes, Current", "terseLabel": "ELOC Commitment Fee Note", "documentation": "Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment." } } }, "auth_ref": [ "r97", "r976" ] }, "vsee_September2024ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "September2024ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementSeptember2024ConvertibleNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to September 2024 Convertible Note.", "label": "September 2024 Convertible Note [Member]", "terseLabel": "September 2024 Convertible Note", "verboseLabel": "September 2024 Convertible Note, at fair value" } } }, "auth_ref": [] }, "vsee_September2024NoteWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "September2024NoteWarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to September 2024 Note Warrants.", "label": "September 2024 Note Warrants [Member]", "terseLabel": "September 2024 Warrants" } } }, "auth_ref": [] }, "vsee_September2024WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "September2024WarrantsMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to September 2024 Warrants.", "label": "September 2024 Warrants [Member]", "terseLabel": "September 2024 Warrants" } } }, "auth_ref": [] }, "vsee_SeriesA1PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SeriesA1PreferredStockMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Series A-1 preferred stock.", "label": "Series A-1 Preferred Stock [Member]", "terseLabel": "Series A-1 Preferred Stock" } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r1144", "r1145", "r1214" ] }, "vsee_ServiceContractsWithHospitalsOrHospitalSystemsPhysicianPracticeGroupsAndOtherUsersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ServiceContractsWithHospitalsOrHospitalSystemsPhysicianPracticeGroupsAndOtherUsersMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to service contracts with hospitals or hospital systems, physician practice groups, and other users.", "label": "Service Contracts With Hospitals Or Hospital Systems, Physician Practice Groups, And Other Users [Member]", "terseLabel": "Service contracts with hospitals or hospital systems, physician practice groups, and other users" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "terseLabel": "Award requisite service period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r958" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r958" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise Price", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r519" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free rate of return", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r521" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted Average Remaining Life In Years" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable, December 31, 2024", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r500" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options exercisable", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r500" ] }, "vsee_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Granted, Weighted Average Remaining Contractual Term", "terseLabel": "Granted" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r502" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r512" ] }, "vsee_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "documentation": "Grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Fair Value", "terseLabel": "Grant date fair value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding, December 31, 2024", "periodStartLabel": "Outstanding, December 31, 2023", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r498", "r499" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, December 31, 2024", "periodStartLabel": "Outstanding, December 31, 2023", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r498", "r499" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Share-based payment award, shares issued in period", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r65" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r494", "r495", "r496", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r518", "r519", "r520", "r521", "r522" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r502" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche One [Member]", "terseLabel": "Tranche One", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-based Compensation", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r493", "r497", "r516", "r517", "r518", "r519", "r522", "r524", "r525", "r526", "r527" ] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Axis]", "documentation": "Information by supplier." } } }, "auth_ref": [] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Domain]", "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharePrice", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share Price", "terseLabel": "Stock Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Share-based payment award, award vesting rights, percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1217" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r518" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable, December 31, 2024", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r65" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Unvested Outstanding, December 31, 2024", "periodStartLabel": "Outstanding, December 31, 2023", "terseLabel": "Non vested", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding, December 31, 2024", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r144" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityKeyAssumptionsUsedInValuingUnvestedOptionsDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Recapitalization value", "verboseLabel": "Stock options vested", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r513" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityStockOptionsDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "negatedLabel": "Vested", "terseLabel": "Vested", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "vsee_SharesAgreedToBeIssuedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SharesAgreedToBeIssuedPeriod", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Duration over which shares agreed to be issued.", "label": "Shares Agreed To Be Issued Period", "terseLabel": "Term for shares to be issued" } } }, "auth_ref": [] }, "vsee_SharesAgreedToBePurchasedMaximumValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SharesAgreedToBePurchasedMaximumValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum value of shares agreed to be purchased.", "label": "Shares Agreed To Be Purchased, Maximum Value", "terseLabel": "Maximum value of shares agreed to be purchased" } } }, "auth_ref": [] }, "vsee_SharesAgreedToBePurchasedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SharesAgreedToBePurchasedPeriod", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Period over which shares agreed to be purchased.", "label": "Shares Agreed To Be Purchased, Period", "terseLabel": "Period to purchase the shares agreed" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesIssued", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares, Issued", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r13" ] }, "vsee_SharesIssuedAsPartOfStockGrantsToVendors": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SharesIssuedAsPartOfStockGrantsToVendors", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of Noncash Financial of Shares Issued as Part of Stock Grants to Vendors.", "label": "Shares Issued As Part of Stock Grants To Vendors", "verboseLabel": "Shares issued as part of stock grants to vendors" } } }, "auth_ref": [] }, "vsee_SharesIssuedForPriorServicesOfPlacementAgentShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SharesIssuedForPriorServicesOfPlacementAgentShares", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for prior services of placement agent", "label": "Shares Issued For Prior Services Of Placement Agent (shares)", "terseLabel": "Shares issued to placement agent" } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesSubjectToMandatoryRedemptionFinancialInstrumentDomain", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Subject to Mandatory Redemption, Financial Instrument [Domain]", "documentation": "Identifying description of each financial instrument that embodies an unconditional obligation requiring the issuer to redeem the securities by transferring the assets at a specified or determinable date (or dates) or upon an event that is certain to occur. Examples are preferred stock or trust preferred securities, each of which has redemption rights beyond the control of the issuer on a specified date or upon an event that is certain to occur." } } }, "auth_ref": [ "r7", "r12" ] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current", "terseLabel": "Due on share purchase", "verboseLabel": "Purchase Amount", "documentation": "The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable within one year of the reporting date or operating cycle, if longer." } } }, "auth_ref": [ "r54" ] }, "vsee_SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Fair value of shares to be issued, at inception and at later date, as share-based compensation for consulting services.", "label": "Shares To Be Issued, At Inception and Later, For Consulting Services Per Agreement", "terseLabel": "Value of shares issued and to be issued under the agreement" } } }, "auth_ref": [] }, "vsee_SignificantAccountingPoliciesOfCompanyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SignificantAccountingPoliciesOfCompanyLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Significant Accounting Policies of The Company [Line Items]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "auth_ref": [] }, "vsee_SignificantAccountingPoliciesOfCompanyTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SignificantAccountingPoliciesOfCompanyTable", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about significant accounting policies.", "label": "Significant Accounting Policies [Table]" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r128", "r229" ] }, "vsee_SponsorAffiliateMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SponsorAffiliateMember", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Sponsor Affiliate.", "label": "Sponsor Affiliate [Member]", "terseLabel": "Sponsor Affiliate" } } }, "auth_ref": [] }, "vsee_SponsorAffiliatesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SponsorAffiliatesMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent information pertains to Sponsor affiliates.", "label": "Sponsor Affiliates [Member]", "terseLabel": "Sponsor Affiliates" } } }, "auth_ref": [] }, "vsee_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SponsorMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to sponsor.", "label": "Sponsor [Member]", "terseLabel": "Sponsor" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and local jurisdiction", "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax." } } }, "auth_ref": [ "r536" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r171", "r172", "r173", "r174", "r197", "r268", "r273", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r289", "r290", "r291", "r299", "r300", "r301", "r302", "r303", "r305", "r306", "r307", "r313", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r392", "r395", "r401", "r402", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r930", "r933", "r934", "r941", "r991", "r1297", "r1298", "r1299", "r1300", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://vseehealth.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/DocumentDocumentAndEntityInformation", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r193", "r209", "r210", "r211", "r232", "r259", "r260", "r262", "r264", "r270", "r271", "r346", "r409", "r412", "r413", "r414", "r418", "r419", "r452", "r453", "r457", "r460", "r467", "r620", "r799", "r800", "r801", "r802", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r835", "r856", "r878", "r895", "r896", "r897", "r898", "r899", "r1119", "r1151", "r1162" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r13", "r107", "r110", "r111", "r195", "r217", "r218", "r219", "r240", "r241", "r242", "r244", "r250", "r253", "r255", "r269", "r347", "r350", "r394", "r469", "r555", "r556", "r563", "r564", "r565", "r567", "r575", "r576", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r621", "r622", "r623", "r624", "r625", "r626", "r631", "r633", "r651", "r758", "r782", "r783", "r784", "r810", "r878" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementGeographicalAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r311", "r312", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r822", "r823", "r824", "r887", "r889", "r892", "r894", "r902", "r904", "r905", "r906", "r907", "r909", "r910", "r911", "r912", "r913", "r919", "r950", "r978", "r979", "r980", "r981", "r982", "r983", "r984", "r985", "r990", "r997", "r1215", "r1297", "r1298", "r1299", "r1301", "r1302", "r1303", "r1304", "r1305", "r1306", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1316", "r1317", "r1318", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r240", "r241", "r242", "r269", "r633", "r701", "r797", "r821", "r827", "r828", "r829", "r830", "r831", "r832", "r835", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r848", "r849", "r850", "r851", "r852", "r854", "r857", "r858", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r878", "r998" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails" ], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "terseLabel": "Consolidated Statement of Cash Flows" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails" ], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS", "terseLabel": "Consolidated Balance Sheet" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementScenarioAxis", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r256", "r492", "r1120", "r1121", "r1160" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r240", "r241", "r242", "r269", "r314", "r633", "r701", "r797", "r821", "r827", "r828", "r829", "r830", "r831", "r832", "r835", "r838", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r846", "r848", "r849", "r850", "r851", "r852", "r854", "r857", "r858", "r864", "r865", "r866", "r867", "r868", "r869", "r870", "r871", "r872", "r873", "r874", "r875", "r878", "r998" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r1027", "r1038", "r1048", "r1081" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock Issued", "terseLabel": "Shares issued", "verboseLabel": "Estimated the fair value of the shares of common stock issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r26", "r27", "r28" ] }, "vsee_StockIssuedConversionOfWorkingCapitalFundsAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedConversionOfWorkingCapitalFundsAdvances", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The value of stock issued upon conversion of working capital funds advances in a non-cash financing activities.", "label": "Stock Issued, Conversion Of Working Capital Funds Advances", "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Shares for iDoc acquisition (in shares)", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r106", "r107", "r141" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountEquityFinancingDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Shares issued upon conversion (in shares)", "verboseLabel": "Conversion of convertible securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r13", "r58", "r107", "r110", "r141", "r437" ] }, "vsee_StockIssuedDuringPeriodSharesConversionOfWorkingCapitalFundAdvances": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodSharesConversionOfWorkingCapitalFundAdvances", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period, Shares, Conversion Of Working Capital Fund Advances", "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances (in shares)", "verboseLabel": "Number of shares of Common Stock upon the settlement in working capital funds advanced" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesDebtIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodSharesDebtIssuance", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock, including warrants and commitment shares, issued during the period pursuant to debt issuance.", "label": "Stock Issued During Period, Shares, Debt Issuance", "terseLabel": "Warrants and commitment shares issued in connection with the September 2024 Note (in shares)" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesDebtSettlement": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodSharesDebtSettlement", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountAdditionalBridgeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountNotesPayableDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to debt settlement or conversion.", "label": "Stock Issued During Period, Shares, Debt Settlement", "terseLabel": "Shares to sponsor debt settlement (shares)", "verboseLabel": "Shares issued in debt settlement or conversion (in shares)" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesEscrowSharesReleasedFromStockPayable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodSharesEscrowSharesReleasedFromStockPayable", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number\nof escrow shares issued from stock payable during the period.", "label": "Stock Issued During Period, Shares, Escrow Shares Released From Stock Payable", "terseLabel": "Escrow shares released from stock payable (in shares)" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountUnderwritersAgreementDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued for services performed by A.G.P.", "verboseLabel": "Shares issued as part of stock grants to vendors (in shares)", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Number of shares issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r13", "r106", "r107", "r141", "r799", "r878", "r896" ] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Equity kicker, shares issued", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesReverseRecapitalization": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to reverse recapitalization.", "label": "Stock Issued During Period, Shares, Reverse Recapitalization", "terseLabel": "Reverse recapitalization (in shares)" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as a settlement of debt during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Settlement of Debt As A Part of Consideration in Acquisitions", "terseLabel": "Shares issued as conversion of iDoc debt as part of the consideration in the acquisition (in shares)" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Shares for iDoc acquisition", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r13", "r107", "r110", "r111", "r141" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Shares issued upon conversion", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r13", "r107", "r110", "r111", "r141" ] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvances", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period, Value, Conversion Of Working Capital Fund Advances", "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances", "verboseLabel": "Value of stock issued during the period upon the settlement in working capital funds advanced" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvancesTroubledDebtRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvancesTroubledDebtRestructuring", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company under troubled debt restructuring.", "label": "Stock Issued During Period, Value, Conversion Of Working Capital Fund Advances, Troubled Debt Restructuring", "terseLabel": "Value of stock issued during period upon conversion of certain working capital funds advanced on debt restructuring" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueDebtIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueDebtIssuance", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSeptember2024NoteDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of stock, including in the form of warrants or commitment shares, issued pursuant to debt issuance during the period.", "label": "Stock Issued During Period, Value, Debt Issuance", "terseLabel": "Warrants and commitment shares issued in connection with the September 2024 Note" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueDebtSettlement", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountSimpleAgreementForFutureEquityDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to debt settlement or conversion during the period.", "label": "Stock Issued During Period, Value, Debt Settlement", "verboseLabel": "Shares issued in debt settlement or conversion" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of escrow stock issued from stock payable during the period.", "label": "Stock Issued During Period, Value, Escrow Shares Released From Stock Payable", "terseLabel": "Escrow shares released from stock payable" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Shares issued as part of stock grants to vendors", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueReverseRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueReverseRecapitalization", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to reverse recapitalization during the period.", "label": "Stock Issued During Period, Value, Reverse Recapitalization", "terseLabel": "Reverse recapitalization" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued to settle debt pursuant to consideration in acquisitions during the period.", "label": "Stock Issued During Period, Value, Settlement of Debt As A Part of Consideration in Acquisition", "terseLabel": "Shares issued as conversion of iDoc debt as part of the consideration in the acquisition" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r66", "r106", "r107", "r141" ] }, "vsee_StockIssuedEscrowSharesReleasedFromStockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedEscrowSharesReleasedFromStockPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued relating to escrow shares released from notes payable in a non-cash financing activities.", "label": "Stock Issued, Escrow Shares Released From Stock Payable", "terseLabel": "Escrow shares released from stock payable" } } }, "auth_ref": [] }, "vsee_StockIssuedForConversionOfUnderwriterFee": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedForConversionOfUnderwriterFee", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The value of stock issued during the period for conversion of underwriter fees in a non-cash financing activities.", "label": "Stock Issued For Conversion Of Underwriter Fee", "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction" } } }, "auth_ref": [] }, "vsee_StockIssuedForDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "StockIssuedForDebtSettlement", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Value of stock issued to settle the debt in a non-cash financing activities.", "label": "Stock Issued For Debt Settlement", "terseLabel": "Shares issued to settled iDoc debt holders" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/StatementConsolidatedBalanceSheets", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Total stockholders' equity (deficit)", "totalLabel": "Total stockholders' equity (deficit)", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r79", "r80", "r81", "r195", "r196", "r218", "r240", "r241", "r242", "r244", "r250", "r253", "r347", "r350", "r394", "r469", "r555", "r556", "r563", "r564", "r565", "r567", "r575", "r576", "r584", "r585", "r586", "r587", "r588", "r589", "r593", "r621", "r622", "r626", "r632", "r651", "r783", "r784", "r808", "r837", "r853", "r879", "r880", "r900", "r1004", "r1153", "r1181", "r1271", "r1329" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' equity (deficit)" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureEquity" ], "lang": { "en-us": { "role": { "label": "Equity [Text Block]", "terseLabel": "Equity", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r138", "r231", "r451", "r453", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r466", "r469", "r591", "r881", "r883", "r901" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Exchange ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r142" ] }, "us-gaap_SubscriptionAndCirculationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubscriptionAndCirculationMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Subscription and Circulation [Member]", "terseLabel": "Subscription fees", "documentation": "Right to receive or access periodic material for specified period of time." } } }, "auth_ref": [ "r1216" ] }, "vsee_SubscriptionProfessionalAndTechnicalEngineeringServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SubscriptionProfessionalAndTechnicalEngineeringServicesMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to combined member of contract liabilities associated with customer deposits for subscription, professional and technical engineering services.", "label": "Subscription, Professional And Technical Engineering Services [Member]", "terseLabel": "Subscription, Professional And Technical Engineering Services" } } }, "auth_ref": [] }, "vsee_SubscriptionServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SubscriptionServicesMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to subscription services.", "label": "Subscription Services [Member]", "terseLabel": "Subscription services" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventLineItems", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Events", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r627", "r662" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Events", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r627", "r662" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTable", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r627", "r662" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r627", "r662" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesForbearanceAgreementDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLineOfCreditDetails", "http://vseehealth.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r627", "r662" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r661", "r663" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernWithinOneYear": { "xbrltype": "booleanItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubstantialDoubtAboutGoingConcernWithinOneYear", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Substantial Doubt about Going Concern, within One Year [true false]", "terseLabel": "Substantial doubt about going concern, within One Year", "documentation": "Indicates (true false) whether there was substantial doubt about ability to continue as going concern within one year after date financial statements are issued." } } }, "auth_ref": [ "r10" ] }, "vsee_SummaryOfRecapitalizationAndEquityImpactTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information relating to the recapitalization and its net equity impact.", "label": "Summary Of Recapitalization And Equity Impact [Table Text Block]", "terseLabel": "Summary of the recapitalization and net equity impact on business combination" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorVendorConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "label": "Supplier Concentration Risk [Member]", "terseLabel": "Major Vendor Concentration Risk", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r131" ] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2024", "localname": "TX", "presentation": [ "http://vseehealth.com/role/DisclosureLeasesOperatingLeasesDetails" ], "lang": { "en-us": { "role": { "label": "TEXAS", "terseLabel": "Texas" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r1074" ] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxPeriodAxis", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Axis]", "documentation": "Information by period subject to enacted tax law." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxPeriodDomain", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_TaxYear2017Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxYear2017Member", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tax Year 2017 [Member]", "terseLabel": "Tax Year 2017", "documentation": "Identified as tax year 2017." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_TaxYear2018Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxYear2018Member", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Tax Year 2018 [Member]", "terseLabel": "Tax Year 2018", "documentation": "Identified as tax year 2018." } } }, "auth_ref": [ "r1248" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAcquiredIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Developed technology", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r18", "r1189", "r1190", "r1191", "r1192", "r1193", "r1195", "r1198", "r1199" ] }, "vsee_TechnologySegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TechnologySegmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the technology segment.", "label": "Technology Segment [Member]", "terseLabel": "Technology" } } }, "auth_ref": [] }, "us-gaap_TechnologyServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TechnologyServiceMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsEffectOfRestatementOnEachFinancialStatementLineItemDetails", "http://vseehealth.com/role/DisclosureRestatementOfPreviouslyIssuedFinancialStatementsNarrativesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Technology Service [Member]", "terseLabel": "Technical engineering fees", "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design." } } }, "auth_ref": [ "r1216" ] }, "vsee_TelehealthAndInstitutionalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TelehealthAndInstitutionalServicesMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to telehealth and institutional services.", "label": "Telehealth and Institutional Services [Member]", "terseLabel": "Telehealth and Institutional Services" } } }, "auth_ref": [] }, "vsee_TelehealthFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TelehealthFeesMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents fees relating to telehealth services.", "label": "Telehealth Fees [Member]", "terseLabel": "Telehealth fees" } } }, "auth_ref": [] }, "vsee_TelehealthSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TelehealthSegmentMember", "presentation": [ "http://vseehealth.com/role/DisclosureReportableSegmentsCapitalExpendituresBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsDepreciationAndAmortizationBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsInterestExpenseBySegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsReconciliationOfConsolidatedSegmentDetails", "http://vseehealth.com/role/DisclosureReportableSegmentsTotalAssetsBySegmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the telehealth segment.", "label": "Telehealth Segment [Member]", "terseLabel": "Telehealth" } } }, "auth_ref": [] }, "vsee_ThisAmericanDocIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThisAmericanDocIncMember", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlowsParentheticals", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficitParentheticals" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to This American Doc, Inc.", "label": "This American Doc, Inc [Member]", "terseLabel": "This American Doc" } } }, "auth_ref": [] }, "vsee_ThresholdBeneficialOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThresholdBeneficialOwnershipPercentage", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold percentage of beneficial ownership of the shares of common stock outstanding.", "label": "Threshold Beneficial Ownership Percentage", "terseLabel": "Threshold beneficial ownership percentage" } } }, "auth_ref": [] }, "vsee_ThresholdGrossProceedsFromCapitalRaisingAsPercentageOfTotalEquityProceedsConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThresholdGrossProceedsFromCapitalRaisingAsPercentageOfTotalEquityProceedsConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold gross proceeds from capital raising as a percentage of total equity proceeds, considered for adjustments of exercise price of warrants.", "label": "Threshold Gross Proceeds From Capital Raising As A Percentage Of Total Equity Proceeds, Considered For Adjustment Of Exercise Price Of Warrants", "terseLabel": "Threshold gross proceeds from capital raising as a percentage of total equity proceeds, considered for adjustment of exercise price of warrants" } } }, "auth_ref": [] }, "vsee_ThresholdIssuePriceForCapitalRaisingInConnectionWithClosingOfInitialBusinessCombinationConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThresholdIssuePriceForCapitalRaisingInConnectionWithClosingOfInitialBusinessCombinationConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold issue price for capital raising in connection with the closing of a Initial Business Combination, considered for adjustments of exercise price of warrants.", "label": "Threshold Issue Price For Capital Raising In Connection With The Closing Of Initial Business Combination, Considered For Adjustment Of Exercise Price Of Warrants", "terseLabel": "Threshold issue price for capital raising purposes in connection with the closing of the initial business combination, considered for adjustment of exercise price of warrants" } } }, "auth_ref": [] }, "vsee_ThresholdMaximumMarketValuePerShareConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThresholdMaximumMarketValuePerShareConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the threshold maximum market value per share, considered for adjustments of exercise price of warrants.", "label": "Threshold Maximum Market Value Per Share, Considered For Adjustment Of Exercise Price Of Warrants", "terseLabel": "Threshold maximum market value per share, considered for adjustment of exercise price of warrants" } } }, "auth_ref": [] }, "vsee_ThresholdOfCumulativeOwnershipChangePercentage": { "xbrltype": "pureItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThresholdOfCumulativeOwnershipChangePercentage", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold of cumulative percentage point increase in ownership.", "label": "Threshold Of Cumulative Ownership Change, Percentage", "terseLabel": "Percentage of threshold of cumulative ownership change" } } }, "auth_ref": [] }, "vsee_ThresholdOwnershipPercentageEligibleToVote": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "ThresholdOwnershipPercentageEligibleToVote", "presentation": [ "http://vseehealth.com/role/DisclosureEquityPreferredStockDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold ownership percentage eligible to vote.", "label": "Threshold Ownership Percentage Eligible to Vote", "terseLabel": "Ownership percentage eligible to vote" } } }, "auth_ref": [] }, "vsee_TidewaterMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TidewaterMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to tidewater.", "label": "Tidewater [Member]", "terseLabel": "Tidewater" } } }, "auth_ref": [] }, "vsee_TotalNumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TotalNumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskContingenciesRobotsPurchaseAgreementDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByIdocDetails" ], "lang": { "en-us": { "role": { "documentation": "Total number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation.", "label": "Total Number Of Deployed Telepresence Robots Rights Considered For Calculating Percentage of Monthly Revenue Generation", "terseLabel": "Total number of deployed telepresence robots" } } }, "auth_ref": [] }, "vsee_TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDeferredRevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability", "terseLabel": "Revenue Recognized" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1066" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r1073" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable and Credit Losses", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r175", "r176", "r177", "r1174", "r1175", "r1176" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r1094" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r1096" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://vseehealth.com/role/DisclosureEquityCommonStockIssuanceObligationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsFairValueInformationDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementElocCommitmentFeeNoteDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementEquityLineOfCreditDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsMeasurementExtensionNoteBifurcatedDerivativeDetails", "http://vseehealth.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r445", "r465", "r590", "r618", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r759", "r962", "r965", "r966", "r967", "r968", "r969", "r970", "r971", "r972", "r977", "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1177", "r1178", "r1179", "r1180", "r1261", "r1264", "r1265", "r1266", "r1268", "r1270" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r1097" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r1098" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r1098" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1096" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r1096" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r1099" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r1097" ] }, "vsee_TwoCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "TwoCustomersMember", "presentation": [ "http://vseehealth.com/role/DisclosureCommitmentsContingenciesAndConcentrationRiskMajorCustomerConcentrationDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCreditRiskAndMajorCustomersSupplierConcentrationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information relating to two customers.", "label": "Two Customers [Member]", "terseLabel": "Two customers" } } }, "auth_ref": [] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "US", "presentation": [ "http://vseehealth.com/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "US" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r1093" ] }, "vsee_UnsecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "UnsecuredPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeHealthFKDhacDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to unsecured promissory note.", "label": "Unsecured Promissory Note [Member]", "terseLabel": "Unsecured Promissory Note" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r38", "r39", "r40", "r180", "r181", "r184", "r185" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VestingAxis", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1217", "r1218", "r1219", "r1220", "r1221", "r1222", "r1223", "r1224", "r1225", "r1226", "r1227", "r1228", "r1229", "r1230", "r1231", "r1232", "r1233", "r1234", "r1235", "r1236", "r1237", "r1238", "r1239", "r1240", "r1241", "r1242" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VestingDomain", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1217", "r1218", "r1219", "r1220", "r1221", "r1222", "r1223", "r1224", "r1225", "r1226", "r1227", "r1228", "r1229", "r1230", "r1231", "r1232", "r1233", "r1234", "r1235", "r1236", "r1237", "r1238", "r1239", "r1240", "r1241", "r1242" ] }, "vsee_VseeLabIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "VseeLabIncMember", "presentation": [ "http://vseehealth.com/role/DisclosureBusinessCombinationRecapitalizationDetails", "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails", "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails", "http://vseehealth.com/role/DisclosureRelatedPartyRelatedPartyTransactionsByVseeLabDetails", "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to VSee Lab, Inc.", "label": "VSee Lab, Inc [Member]", "terseLabel": "VSee Lab", "verboseLabel": "VSee Lab, Inc" } } }, "auth_ref": [] }, "vsee_VseeLabStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "VseeLabStockholdersMember", "presentation": [ "http://vseehealth.com/role/DisclosureOrganizationAndDescriptionOfBusinessDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to VSee Lab stockholders.", "label": "VSee Lab Stockholders [Member]", "terseLabel": "VSee Lab stockholders" } } }, "auth_ref": [] }, "vsee_VseeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "VseeNoteMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExchangeNoteExchangeFinancingDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfCashFlows", "http://vseehealth.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to VSee Note.", "label": "Vsee Note [Member]", "terseLabel": "VSee Note" } } }, "auth_ref": [] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r1062" ] }, "vsee_WarrantInstrumentsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WarrantInstrumentsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for warrant instruments.", "label": "Warrant Instruments, Policy [Policy Text Block]", "terseLabel": "Warrant Instruments" } } }, "auth_ref": [] }, "vsee_WarrantPeriodForExerciseAfterClosingOfInitialPublicOffering": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WarrantPeriodForExerciseAfterClosingOfInitialPublicOffering", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period after closing of Initial Public Offering, that the warrants become exercisable.", "label": "Warrant, Period For Exercise After Closing of Initial Public Offering", "terseLabel": "Period after closing of Initial Public Offering, that the warrants become exercisable" } } }, "auth_ref": [] }, "vsee_WarrantPeriodForExerciseAfterCompletionOfInitialBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WarrantPeriodForExerciseAfterCompletionOfInitialBusinessCombination", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period after completion of Initial Business Combination, that the warrants become exercisable.", "label": "Warrant, Period For Exercise After Completion Of Initial Business Combination", "terseLabel": "Period after closing of Initial Business Combination, that the warrants become exercisable" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Warrants" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountExtensionNoteExtensionFinancingDetails", "http://vseehealth.com/role/DisclosureWarrantsBridgeExtensionAndSeptember2024WarrantsDetails", "http://vseehealth.com/role/DisclosureWarrantsPublicAndPrivateWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Weighted Average remaining life in years", "verboseLabel": "Exercise period", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1264", "r1265", "r1266" ] }, "vsee_WarrantsAndRightsOutstandingWeightedAverageRemainingTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WarrantsAndRightsOutstandingWeightedAverageRemainingTerm", "presentation": [ "http://vseehealth.com/role/DisclosureWarrantsWarrantsIssuedAndOutstandingDetails" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining term of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Weighted Average Remaining Term", "terseLabel": "Weighted Average Remaining Life in Years" } } }, "auth_ref": [] }, "vsee_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WarrantsMember", "presentation": [ "http://vseehealth.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to warrants.", "label": "Warrants [Member]", "terseLabel": "Warrants" } } }, "auth_ref": [] }, "vsee_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WarrantsTextBlock", "presentation": [ "http://vseehealth.com/role/DisclosureWarrants" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of Warrants.", "label": "Warrants [Text Block]", "terseLabel": "Warrants" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]", "terseLabel": "Excluded securities:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average number of common shares outstanding, diluted (in shares)", "verboseLabel": "Weighted average shares outstanding - diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r258", "r264" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://vseehealth.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://vseehealth.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of common shares outstanding, basic (in shares)", "verboseLabel": "Weighted average shares outstanding - basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r257", "r264" ] }, "vsee_WhackyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20241231", "localname": "WhackyMember", "presentation": [ "http://vseehealth.com/role/DisclosureLineOfCreditAndNotesPayableNetOfDiscountLoanConversionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information related to Whacky.", "label": "Whacky [Member]", "terseLabel": "Whacky" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r1060" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481648/480-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "SubTopic": "40", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479710/205-40-50-13" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481648/480-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "45", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481679/480-10-45-2A" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481648/480-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-5" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-40/tableOfContent" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.1.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r924": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r925": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r926": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r927": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r928": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r929": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r930": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r931": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r932": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r933": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r934": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r935": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r936": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r937": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r938": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r939": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r940": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r941": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r942": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r943": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r944": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r945": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r946": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r947": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r948": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r949": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r950": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r951": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r952": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r954": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r955": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r956": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r957": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r958": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r959": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r960": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r961": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r962": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r963": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r964": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r965": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r966": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r967": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r968": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r969": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r970": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r971": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r972": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r973": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r974": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r975": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r976": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r977": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r978": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r979": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r980": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r981": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r982": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r983": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r984": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r985": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r986": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r987": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r988": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r989": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r990": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r991": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r992": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r993": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r994": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r995": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r996": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r997": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r998": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r999": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1000": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r1006": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1007": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1008": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1009": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r1010": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1011": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1012": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r1013": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r1014": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r1015": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r1016": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r1017": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r1018": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r1019": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2" }, "r1020": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r1021": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "ii" }, "r1022": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "2", "Subparagraph": "iii" }, "r1023": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1024": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1025": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1026": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1027": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1028": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1029": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1030": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1031": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1032": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1033": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1034": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1035": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1036": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1037": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1038": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1039": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1040": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1041": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1042": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1043": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1044": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1045": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1046": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1047": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1048": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1049": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1050": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1051": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1052": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1053": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1054": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1055": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1056": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1057": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1058": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1059": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r1060": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r1061": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r1062": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r1063": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r1064": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r1065": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r1066": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1067": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1068": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1069": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1070": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1071": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1072": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1073": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1074": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1075": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1076": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r1077": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1078": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1079": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1080": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1081": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1082": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1083": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1084": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1085": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1086": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1087": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1088": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1089": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1090": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1091": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1092": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1093": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1094": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1095": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1096": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1097": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1098": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1099": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1100": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1101": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r1102": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r1103": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r1104": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r1105": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r1106": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r1107": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r1108": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2" }, "r1109": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "i" }, "r1110": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "ii" }, "r1111": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "2", "Subparagraph": "iii" }, "r1112": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r1113": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r1114": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r1115": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r1116": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1117": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r1118": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r1119": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r1120": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r1121": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1125": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r1126": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1127": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1128": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r1129": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1130": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1131": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r1132": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r1133": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r1134": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1135": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org/705/tableOfContent" }, "r1136": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r1137": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1138": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1139": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1140": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1141": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1142": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1143": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r1148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r1150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r1157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r1158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r1159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12" }, "r1160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r1161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r1162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r1163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r1165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r1166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r1167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r1172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r1173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r1174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1" }, "r1177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r1178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r1183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r1184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r1185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r1186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r1189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r1190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1203": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1204": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1205": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1206": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1207": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1208": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1209": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1210": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r1211": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1212": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r1213": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r1214": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r1215": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1216": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1217": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1218": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1219": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1220": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1221": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1222": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1223": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1224": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1225": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1226": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1227": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1228": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r1245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r1246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r1247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r1248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r1250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r1251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6" }, "r1252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r1255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1" }, "r1256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1" }, "r1257": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2" }, "r1258": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "15", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815-15/tableOfContent" }, "r1259": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1260": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1261": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r1262": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1263": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1264": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1265": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1266": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1267": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1268": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1269": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1270": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1271": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1272": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r1275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r1278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1279": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r1280": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r1281": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r1282": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1283": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1284": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r1285": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1286": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1287": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1288": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1289": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1290": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1291": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1292": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1293": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1294": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1295": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1296": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1297": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1298": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1299": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1300": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1301": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1302": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1303": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1304": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1305": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1306": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1307": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1308": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1309": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } }